Cover Page
Cover Page - USD ($) | 12 Months Ended | ||
Mar. 31, 2021 | May 20, 2021 | Sep. 30, 2020 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Mar. 31, 2021 | ||
Document Transition Report | false | ||
Entity File Number | 000-19599 | ||
Entity Registrant Name | WORLD ACCEPTANCE CORPORATION | ||
Entity Incorporation, State or Country Code | SC | ||
Entity Tax Identification Number | 57-0425114 | ||
Entity Address, Address Line One | 104 S. Main St. | ||
Entity Address, City or Town | Greenville | ||
Entity Address, State or Province | SC | ||
Entity Address, Postal Zip Code | 29601 | ||
City Area Code | (864) | ||
Local Phone Number | 298-9800 | ||
Title of 12(b) Security | Common Stock, no par value | ||
Trading Symbol | WRLD | ||
Security Exchange Name | NASDAQ | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Accelerated Filer | ||
Entity Emerging Growth Company | false | ||
Entity Small Business | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 487,405,940 | ||
Entity Common Stock, Shares Outstanding | 6,775,239 | ||
Documents Incorporated by Reference | Portions of the Registrant's definitive Proxy Statement pertaining to the 2021 Annual Meeting of Shareholders ("the Proxy Statement") to be filed pursuant to Regulation 14A are incorporated herein by reference into Part III hereof. | ||
Entity Central Index Key | 0000108385 | ||
Document Fiscal Year Focus | 2021 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false | ||
Current Fiscal Year End Date | --03-31 | ||
ICFR Auditor Attestation Flag | true |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) | Mar. 31, 2021 | Mar. 31, 2020 |
ASSETS | ||
Cash and cash equivalents | $ 15,746,454 | $ 11,618,922 |
Gross loans receivable | 1,104,746,261 | 1,209,871,366 |
Less: | ||
Unearned interest, insurance and fees | (279,364,584) | (308,980,724) |
Allowance for credit losses | (91,722,288) | (96,487,856) |
Loans receivable, net | 733,659,389 | 804,402,786 |
Right-of-use asset | 90,055,572 | 101,686,918 |
Property and equipment, net | 26,340,037 | 24,761,108 |
Deferred income taxes, net | 24,992,742 | 23,257,985 |
Other assets, net | 31,423,134 | 28,547,950 |
Goodwill | 7,370,791 | 7,370,791 |
Intangible assets, net | 23,537,517 | 24,448,477 |
Assets held for sale (Note 17) | 1,143,528 | 3,991,498 |
Total assets | 954,269,164 | 1,030,086,435 |
Liabilities: | ||
Senior notes payable | 405,007,500 | 451,100,000 |
Income taxes payable | 11,575,861 | 4,965,302 |
Lease liability | 91,718,075 | 102,759,386 |
Accounts payable and accrued expenses | 41,040,287 | 59,298,680 |
Total liabilities | 549,341,723 | 618,123,368 |
Commitments and contingencies | ||
Shareholders' equity: | ||
Preferred stock, no par value Authorized 5,000,000, no shares issued or outstanding | 0 | 0 |
Common stock, no par value Authorized 95,000,000 shares; issued and outstanding 6,805,294 and 7,807,834 shares at March 31, 2021 and March 31, 2020, respectively | 0 | 0 |
Additional paid-in capital | 255,590,674 | 227,214,577 |
Retained earnings | 149,336,767 | 184,748,490 |
Total shareholders' equity | 404,927,441 | 411,963,067 |
Total liabilities and shareholders' equity | $ 954,269,164 | $ 1,030,086,435 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Mar. 31, 2021 | Mar. 31, 2020 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in dollars per share) | $ 0 | $ 0 |
Preferred stock, shares authorized (in shares) | 5,000,000 | 5,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0 | $ 0 |
Common stock, shares authorized (in shares) | 95,000,000 | 95,000,000 |
Common stock, shares issued (in shares) | 6,805,294 | 7,807,834 |
Common stock, shares outstanding (in shares) | 6,805,294 | 7,807,834 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) | 12 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Revenues: | |||
Interest and fee income | $ 451,113,502 | $ 508,326,771 | $ 469,154,277 |
Insurance income, net and other income | 74,419,765 | 81,702,244 | 75,388,648 |
Total revenues | 525,533,267 | 590,029,015 | 544,542,925 |
Expenses: | |||
Provision for credit losses | 86,244,714 | 181,730,182 | 148,426,578 |
General and administrative expenses: | |||
Personnel | 184,620,515 | 203,774,574 | 180,561,501 |
Occupancy and equipment | 56,160,268 | 54,237,835 | 48,751,691 |
Advertising | 17,190,676 | 24,304,023 | 22,482,553 |
Amortization of intangible assets | 5,474,240 | 5,010,626 | 1,527,656 |
Other | 38,740,591 | 60,166,202 | 34,980,314 |
Total general and administrative expenses | 302,186,290 | 347,493,260 | 288,303,715 |
Interest expense | 25,698,836 | 25,896,130 | 17,934,060 |
Total expenses | 414,129,840 | 555,119,572 | 454,664,353 |
Income from continuing operations before income taxes | 111,403,427 | 34,909,443 | 89,878,572 |
Income taxes | 23,120,599 | 6,751,965 | 15,981,057 |
Income from continuing operations | 88,282,828 | 28,157,478 | 73,897,515 |
Income from discontinued operations before disposal of discontinued operations and income taxes | 0 | 0 | 2,341,825 |
Loss on disposal of discontinued operations | 0 | 0 | (38,377,623) |
Income taxes (benefit) | 0 | 0 | 626,583 |
Income (loss) from discontinued operations | 0 | 0 | (36,662,381) |
Net income | $ 88,282,828 | $ 28,157,478 | $ 37,235,134 |
Net income per common share from continuing operations: | |||
Basic (in dollars per share) | $ 13.59 | $ 3.66 | $ 8.22 |
Diluted (in dollars per share) | 13.23 | 3.54 | 8.03 |
Net income (loss) per common share from discontinued operations: | |||
Basic (in dollars per share) | 0 | 0 | (4.08) |
Diluted (in dollars per share) | 0 | 0 | (3.98) |
Net income per common share: | |||
Basic (in dollars per share) | 13.59 | 3.66 | 4.14 |
Diluted (in dollars per share) | $ 13.23 | $ 3.54 | $ 4.05 |
Weighted average common shares outstanding: | |||
Basic (in shares) | 6,493,898 | 7,688,242 | 8,994,036 |
Diluted (in shares) | 6,672,110 | 7,952,900 | 9,204,377 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) | 12 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Statement of Comprehensive Income [Abstract] | |||
Net income | $ 88,282,828 | $ 28,157,478 | $ 37,235,134 |
Foreign currency translation adjustments | 0 | 0 | (5,235,838) |
Reclassification of cumulative foreign currency translation adjustments due to sale of Mexico business | 0 | 0 | 31,290,918 |
Comprehensive income | $ 88,282,828 | $ 28,157,478 | $ 63,290,214 |
CONSOLIDATED STATEMENTS OF SHAR
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) | Total | Impact of ASC 326 adoption | Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Loss, net |
Beginning balance at Mar. 31, 2018 | $ 541,107,852 | $ 175,887,227 | $ 391,275,705 | $ (26,055,080) | ||
Beginning balance (shares) at Mar. 31, 2018 | 9,119,443 | |||||
Increase (Decrease) in Shareholders' Equity [Roll Forward] | ||||||
Proceeds from exercise of stock options (in shares) | 92,428 | |||||
Proceeds from exercise of stock options | 5,997,948 | 5,997,948 | ||||
Common stock repurchases (in shares) | (665,020) | |||||
Common stock repurchases | (74,519,863) | (74,519,863) | ||||
Restricted common stock expense under stock option plan, net of cancellations (in shares) | 737,267 | |||||
Restricted common stock expense under stock option plan, net of cancellations | 12,248,507 | 12,248,507 | ||||
Stock option expense | 3,991,967 | 3,991,967 | ||||
Other comprehensive loss | (5,235,838) | (5,235,838) | ||||
Reclassification of cumulative foreign currency translation adjustments due to sale of Mexico business | 31,290,918 | 31,290,918 | ||||
Net income | 37,235,134 | 37,235,134 | ||||
Ending balance (shares) at Mar. 31, 2019 | 9,284,118 | |||||
Ending balance at Mar. 31, 2019 | 552,116,625 | 198,125,649 | 353,990,976 | 0 | ||
Increase (Decrease) in Shareholders' Equity [Roll Forward] | ||||||
Proceeds from exercise of stock options (in shares) | 69,481 | |||||
Proceeds from exercise of stock options | 4,612,926 | 4,612,926 | ||||
Common stock repurchases (in shares) | (1,520,679) | |||||
Common stock repurchases | (197,399,964) | (197,399,964) | ||||
Restricted common stock expense under stock option plan, net of cancellations (in shares) | (25,086) | |||||
Restricted common stock expense under stock option plan, net of cancellations | 18,953,119 | 18,953,119 | ||||
Stock option expense | 5,522,883 | 5,522,883 | ||||
Reclassification of cumulative foreign currency translation adjustments due to sale of Mexico business | 0 | |||||
Net income | $ 28,157,478 | 28,157,478 | ||||
Ending balance (shares) at Mar. 31, 2020 | 7,807,834 | 7,807,834 | ||||
Ending balance at Mar. 31, 2020 | $ 411,963,067 | $ (21,242,249) | 227,214,577 | 184,748,490 | 0 | |
Increase (Decrease) in Shareholders' Equity [Roll Forward] | ||||||
Proceeds from exercise of stock options (in shares) | 165,237 | |||||
Proceeds from exercise of stock options | 12,268,554 | 12,268,554 | ||||
Common stock repurchases (in shares) | (1,129,875) | |||||
Common stock repurchases | (102,452,302) | (102,452,302) | ||||
Restricted common stock expense under stock option plan, net of cancellations (in shares) | (37,902) | |||||
Restricted common stock expense under stock option plan, net of cancellations | 12,302,869 | 12,302,869 | ||||
Stock option expense | 3,804,674 | 3,804,674 | ||||
Reclassification of cumulative foreign currency translation adjustments due to sale of Mexico business | 0 | |||||
Net income | $ 88,282,828 | 88,282,828 | ||||
Ending balance (shares) at Mar. 31, 2021 | 6,805,294 | 6,805,294 | ||||
Ending balance at Mar. 31, 2021 | $ 404,927,441 | $ 255,590,674 | $ 149,336,767 | $ 0 |
CONSOLIDATED STATEMENTS OF SH_2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Parenthetical) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Jun. 30, 2020 | Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Statement of Stockholders' Equity [Abstract] | ||||
Accounting Standards Update [Extensible List] | us-gaap:AccountingStandardsUpdate201605Member | |||
Issuance of restricted common stock under stock option plan (in shares) | $ 3,173,735 | $ 4,476,159 | $ 1,394,835 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS | 12 Months Ended | ||
Mar. 31, 2021USD ($) | Mar. 31, 2020USD ($) | Mar. 31, 2019USD ($) | |
Cash flow from operating activities: | |||
Net income | $ 88,282,828 | $ 28,157,478 | $ 37,235,134 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Loss on sale of discontinued operations | 0 | 0 | 38,377,623 |
Loss on assets held for sale | 37,579 | 251,263 | 0 |
Amortization of intangible assets | 5,474,240 | 5,010,626 | 1,527,656 |
Amortization of historic tax credits | 1,736,384 | 868,192 | 0 |
Amortization of debt issuance costs | 659,292 | 517,499 | 592,549 |
Provision for credit losses | 86,244,714 | 181,730,182 | 148,426,578 |
Depreciation | 6,945,581 | 7,147,966 | 6,608,348 |
Loss on sale of property and equipment | 2,812,404 | 339,259 | 93,199 |
Deferred income tax expense (benefit) | 5,651,362 | 572,914 | (3,655,751) |
Compensation related to stock option and restricted stock plans, net of taxes and adjustments | 19,281,278 | 28,952,161 | 17,635,309 |
Gain on sale of finance receivables | (24,667) | 0 | 0 |
Gain on company-owned life insurance | 1,064,897 | 0 | 0 |
Change in accounts: | |||
Other assets, net | (4,828,957) | (9,470,838) | (5,507,068) |
Income taxes payable and receivable | 6,610,559 | (6,584,895) | (2,547,222) |
Accounts payable and accrued expenses | (18,258,393) | 19,917,429 | 5,877,916 |
Net cash provided by operating activities | 199,559,307 | 257,409,236 | 244,664,271 |
Cash flows from investing activities: | |||
Increase in loans receivable, net | (29,343,372) | (183,482,267) | (190,976,279) |
Net assets acquired from business combinations and asset acquisitions, primarily loans | (15,210,973) | (47,100,694) | (33,922,279) |
Increase in intangible assets from acquisitions | (4,563,280) | (14,455,278) | (10,223,508) |
Purchases of property and equipment | (11,683,857) | (11,277,780) | (9,805,084) |
Proceeds from sale of property and equipment | 346,943 | 284,869 | 466,806 |
Proceeds from the sale of assets held for sale | 2,810,391 | 0 | 0 |
Proceeds from the sale of finance receivables | 449,327 | 0 | 0 |
Proceeds from sale of discontinued operations | 0 | 0 | 37,494,505 |
Proceeds from company-owned life insurance | 1,997,279 | 0 | 0 |
Net cash used in investing activities | (55,197,542) | (256,031,150) | (206,965,839) |
Cash flow from financing activities: | |||
Borrowings from senior notes payable | 310,984,250 | 540,691,400 | 364,290,000 |
Payments on senior notes payable | (357,076,750) | (341,531,400) | (357,250,000) |
Debt issuance costs associated with senior notes payable | (784,250) | (991,400) | (240,000) |
Proceeds from exercise of stock options | 12,268,554 | 4,612,926 | 5,997,948 |
Payments for taxes related to net share settlement of equity awards | (3,173,735) | (4,476,159) | (1,394,835) |
Repurchase of common stock | (102,452,302) | (197,399,964) | (74,519,863) |
Excess tax expense from exercise of stock options | 0 | 0 | 0 |
Net cash provided by (used in) financing activities | (140,234,233) | 905,403 | (63,116,750) |
Effects of foreign currency fluctuations on cash and cash equivalents | 0 | 0 | 2,667,447 |
Net change in cash and cash equivalents | 4,127,532 | 2,283,489 | (22,750,871) |
Cash and cash equivalents at beginning of year from continuing operations | 11,618,922 | 9,335,433 | 12,473,833 |
Cash and cash equivalents at beginning of year from discontinued operations | 0 | 0 | 19,612,471 |
Cash and cash equivalents at end of year | 15,746,454 | 11,618,922 | 9,335,433 |
Cash and cash equivalents at end of year from continuing operations | 15,746,454 | 11,618,922 | 9,335,433 |
Cash and cash equivalents at end of year from discontinued operations | 0 | 0 | |
Supplemental Disclosures: | |||
Interest paid during the year | 24,993,898 | 23,942,122 | 16,835,789 |
Income taxes paid during the year | $ 14,857,555 | $ 15,711,692 | $ 23,259,590 |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies The Company's accounting and reporting policies are in accordance with GAAP and conform to general practices within the finance company industry. The following is a description of the more significant of these policies used in preparing the Consolidated Financial Statements. Nature of Operations The Company is a small-dollar consumer finance (installment loan) company headquartered in Greenville, South Carolina that offers short-term small loans, medium-term larger loans, related credit insurance products and ancillary products and services to individuals who have limited access to other sources of consumer credit. It also offers income tax return preparation services to its customer base and to others. As of March 31, 2021, the Company operated 1,205 branches in Alabama, Georgia, Idaho, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Missouri, New Mexico, Oklahoma, South Carolina, Tennessee, Texas, Utah, and Wisconsin. Branches in the aforementioned states operate under one of the following names: Amicable Finance, Colonial Finance, Freeman Finance, General Credit, Midwestern Loans, World Acceptance, or World Finance. On August 3, 2018 the Company and its affiliates completed the sale of the Company's Mexico operating segment in its entirety, effective as of July 1, 2018. Thus, the Company operated no branches in Mexico as of March 31, 2021 or 2020. During the first quarter of fiscal 2019, branches in Mexico operated under the name Préstamos Avance or Pr é stamos Viva. The Company is subject to numerous lending regulations that vary by jurisdiction. Principles of Consolidation The Consolidated Financial Statements include the accounts of World Acceptance Corporation and its wholly-owned subsidiaries (the “Company”). Subsidiaries consist of operating entities in various states, ParaData Financial Systems (a software company acquired during fiscal 1994), and WAC Insurance Company, Ltd. (a captive reinsurance company established in fiscal 1994). All significant inter-company balances and transactions have been eliminated in consolidation. The financial statements of the Company’s former foreign subsidiaries in Mexico were prepared using the local currency as the functional currency. Assets and liabilities of these subsidiaries were translated into U.S. dollars at the then-current exchange rate while income and expense are translated at an average exchange rate for the applicable period. The resulting translation gains and losses were recognized as a component of equity in “Accumulated Other Comprehensive Loss, net.” Use of Estimates in the Preparation of Consolidated Financial Statements The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The most significant item subject to such estimates and assumptions that could materially change in the near term is the allowance for credit losses. Reclassification Certain prior period amounts have been reclassified to conform to the current presentation. Such reclassifications had no impact on previously reported net income or shareholders' equity. Business Segments The Company reports operating segments in accordance with FASB ASC Topic 280. Operating segments are components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and assess performance. FASB ASC Topic 280 requires that a public enterprise report a measure of segment profit or loss, certain specific revenue and expense items, segment assets, information about the way that the operating segments were determined and other items. The Company has one reportable segment. The other revenue generating activities of the Company, including the sale of insurance products, income tax preparation, and the automobile club, are done within the existing branch network in conjunction with or as a complement to the lending operations. There is no discrete financial information available for these activities, and they do not meet the criteria under FASB ASC Topic 280 to be considered operating segments. Cash and Cash Equivalents For purposes of the statement of cash flows, the Company considers all highly liquid investments with a maturity of three months or less from the date of original issuance to be cash equivalents. As of March 31, 2021 and 2020 the Company had $7.0 million and $5.4 million, respectively, in restricted cash associated with its captive insurance subsidiary that reinsures a portion of the credit insurance sold in connection with loans made by the Company. Loans and Interest and Fee Income The Company is licensed to originate consumer loans in the states of Alabama, Georgia, Idaho, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Missouri, New Mexico, Oklahoma, South Carolina, Texas, Tennessee, Utah, and Wisconsin. During fiscal 2021, 2020, and 2019 the Company originated loans generally ranging up to $3,500, with terms of 48 months or fewer. Experience indicates that a majority of the consumer loans are refinanced, and the Company accounts for the majority of the refinancings as new loans. Generally a customer must make multiple payments in order to qualify for refinancing. Furthermore, the Company's lending policy has predetermined lending amounts so that in most cases a refinancing will result in advancing additional funds. The Company believes that the advancement of additional funds constitutes more than a minor modification to the terms of the existing loan if the present value of the cash flows under the terms of the new loan will be 10% or more of the present value of the remaining cash flows under the terms of the original loan. The following table sets forth information about our loan products for fiscal 2021: Minimum Origination Maximum Origination Minimum Term Maximum Term Small loans $ 250 $ 2,450 4 30 Large loans 2,500 21,400 12 48 Tax advance loans 100 5,000 8 8 Gross loans receivable at March 31, 2021 and 2020 consisted of the following: 2021 2020 Small loans $ 620,959,979 $ 761,364,753 Large loans 475,470,271 442,683,915 Tax advance loans 8,316,011 5,822,698 Total gross loans $ 1,104,746,261 $ 1,209,871,366 Fees received and direct costs incurred for the origination of loans are deferred and amortized to interest income over the contractual lives of the loans using the interest method. Unamortized amounts are recognized in income at the time that loans are refinanced or paid in full except for those refinancings that do not constitute a more than minor modification. Loans are carried at the gross amount outstanding, reduced by unearned interest and insurance income, net of deferred origination fees and direct costs and an allowance for credit losses. The Company recognizes interest and fee income using the interest method. Charges for late payments are credited to income when collected. With the exception of tax advance loans, which are interest free, the Company offers its loans at the prevailing statutory rates for terms not to exceed 48 months. Management believes that the carrying value approximates the fair value of its loan portfolio. Nonaccrual Policy The accrual of interest is discontinued when a loan is 61 days or more past the contractual due date. When the interest accrual is discontinued, all unpaid accrued interest is reversed against interest income. While a loan is on nonaccrual status, interest revenue is recognized only when a payment is received. Once a loan moves to nonaccrual status, it remains in nonaccrual status until it is paid out, charged off or refinanced. Allowance for Credit Losses Refer to Note 2, “Allowance for Credit Losses and Credit Quality Indicators,” in this Annual Report on Form 10-K for information regarding the Company's adoption of the CECL allowance model on April 1, 2020 and a description of the methodology it utilizes. Impaired Loans The Company defines impaired loans as bankrupt accounts and accounts 91 days or more past due on a recency basis. In accordance with the Company’s charge-off policy, once a loan is deemed uncollectible, 100% of the net investment is charged off, except in the case of a borrower who has filed for bankruptcy. As of March 31, 2021, bankrupt accounts that had not been charged off were approximately $3.2 million. Bankrupt accounts 91 days or more past due on a recency basis are reserved at 100% of the gross loan balance. The Company also considers any accounts 91 days or more past due on a recency basis to be impaired, and such accounts are reserved at 100% of the gross loan balance. Property and Equipment Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is recorded using the straight-line method over the estimated useful life of the related asset as follows: buildings, 25 to 40 years; furniture and fixtures, 5 to 10 years; equipment, 3 to 7 years; and vehicles, 3 years. Amortization of leasehold improvements is recorded using the straight-line method over the lesser of the estimated useful life of the asset or the term of the lease. Additions to premises and equipment and major replacements or improvements are added at cost. Maintenance, repairs, and minor replacements are charged to operating expense as incurred. When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the consolidated statement of operations. Operating Leases The Company’s branch leases typically have a lease term of three Other Assets Other assets include cash surrender value of life insurance policies, prepaid expenses, debt issuance costs, and other deposits. Intangible Assets and Goodwill Intangible assets include the cost of acquiring existing customers ("customer lists"), and the fair value assigned to non-compete agreements. Customer lists are amortized on a straight line or accelerated basis over their estimated period of benefit, ranging from 8 to 23 years with a weighted average of approximately 9.5 years. Non-compete agreements are amortized on a straight line basis over the term of the agreement, ranging from 3 to 5.3 years with a weighted average of approximately 5.0 years. Customer lists are allocated at a branch level and are evaluated for impairment at a branch level when a triggering event occurs, in accordance with FASB ASC Topic 360-10-05. If a triggering event occurs, the impairment loss to the customer list is generally the remaining unamortized customer list balance. In most acquisitions, the original fair value of the customer list allocated to a branch is less than $100,000, and management believes that in the event a triggering event were to occur, the impairment loss to an unamortized customer list would be immaterial. Non-compete agreements are valued at the stated amount paid to the other party for these agreements, which the Company believes approximates the fair value. The fair value of the customer lists is based on a valuation model that utilizes the Company’s historical data to estimate the value of any acquired customer lists. In a business combination, the remaining excess of the purchase price over the fair value of the tangible assets, customer list, and non-compete agreements is allocated to goodwill. The branches the Company acquires are small, privately-owned branches, which do not have sufficient historical data to determine customer attrition. The Company believes that the customers acquired have the same characteristics and perform similarly to its customers. Therefore, the Company utilized the attrition patterns of its customers when developing the estimate of attrition for acquired customers. This estimation method is re-evaluated periodically. The Company evaluates goodwill annually for impairment in the fourth quarter of the fiscal year using the market value-based approach. The Company has one reporting unit, and the Company has multiple components, the lowest level of which is individual branches. The Company’s components are aggregated for impairment testing because they have similar economic characteristics. Impairment of Long-Lived Assets The Company assesses impairment of long-lived assets, including property and equipment and intangible assets, whenever changes or events indicate that the carrying amount may not be recoverable. The Company assesses impairment of these assets generally at the branch level based on the operating cash flows of the branch and the Company’s plans for branch closings. The Company will write down such assets to fair value if, based on an analysis, the sum of the expected future undiscounted cash flows is less than the carrying amount of the assets. The Company did not record any impairment charges for the fiscal year ended 2021, 2020, or 2019. Fair Value of Financial Instruments FASB ASC Topic 825 requires disclosures about the fair value of all financial instruments, regardless of whether the financial instrument is recognized on the balance sheet, for which it is practicable to estimate that value. In cases where quoted market prices are not available, fair values are based on estimates using present value or other valuation techniques. The Company’s financial instruments for the periods reported consist of the following: cash and cash equivalents, loans receivable and senior notes payable. Fair value approximates carrying value for all of these instruments. Loans receivable are originated at prevailing market rates and have an average life of approximately 8 months. Given the short-term nature of these loans, they are continually repriced at current market rates. The Company’s revolving credit facility has a variable rate based on a margin over LIBOR and reprices with any changes in LIBOR. Insurance Premiums and Commissions Insurance premiums for credit life, accident and health, property and unemployment insurance written in connection with certain loans, net of refunds and applicable advance insurance commissions retained by the Company, are remitted monthly to an insurance company. All commissions are credited to unearned insurance commissions and recognized as income over the life of the related insurance contracts. The Company recognizes insurance income using the Rule of 78s method for credit life (decreasing term), credit accident and health, unemployment insurance and the Pro Rata method for credit life (level term) and credit property. Non-filing Insurance Non-filing insurance premiums are charged on certain loans in lieu of recording and perfecting the Company's security interest in the assets pledged. The premiums and recoveries are remitted to a third party insurance company and are not reflected in the accompanying Consolidated Financial Statements (see Note 8). Claims paid by the third party insurance company result in a reduction to loan losses. Certain losses related to such loans, which are not recoverable through life, accident and health, property, or unemployment insurance claims are reimbursed through non-filing insurance claims subject to policy limitations. Any remaining losses are charged to the allowance for credit losses. Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment related to additional facts and circumstances occurs. Earnings Per Share Earnings per share (“EPS”) is computed in accordance with FASB ASC Topic 260. Basic EPS includes no dilution and is computed by dividing net income by the weighted-average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution of securities that could share in the earnings of the Company. Potential common stock included in the diluted EPS computation consists of stock options and restricted stock, which are computed using the treasury stock method. See Note 11 for the reconciliation of the numerators and denominators for basic and dilutive EPS calculations. Stock-Based Compensation FASB ASC Topic 718-10 requires companies to recognize in the income statement the grant-date fair value of stock options and other equity-based compensation issued to employees. FASB ASC Topic 718-10 does not change the accounting guidance for share-based payment transactions with parties other than employees provided in FASB ASC Topic 718-10. Under FASB ASC Topic 718-10, the way an award is classified will affect the measurement of compensation cost. Liability-classified awards are remeasured to fair value at each balance-sheet date until the award is settled. Equity-classified awards are measured at grant-date fair value, amortized over the subsequent vesting period, and are not subsequently remeasured. The fair value of non-vested stock awards for the purposes of recognizing stock-based compensation expense is the market price of the stock on the grant date. The fair value of options is estimated on the grant date using the Black-Scholes option pricing model (see Note 12). At March 31, 2021, the Company had several share-based employee compensation plans, which are described more fully in Note 12. Share Repurchases On March 12, 2020, the Board of Directors authorized the Company to repurchase up to $30.0 million of the Company’s outstanding common stock, inclusive of the amount that remains available for repurchase under prior repurchase authorizations. As of March 31, 2021, the Company had $21.4 million in aggregate remaining repurchase capacity. The timing and actual number of shares of common stock repurchased will depend on a variety of factors, including the stock price, corporate and regulatory requirements, restrictions under the revolving credit facility and other market and economic conditions. The Company continues to believe stock repurchases are a viable component of the Company’s long-term financial strategy and an excellent use of excess cash when the opportunity arises. However, our revolving credit agreement limits share repurchases to 50% of consolidated adjusted net income in any fiscal year commencing with the fiscal year ending March 31, 2017 without prior written consent of the lenders. As of March 31, 2021 our debt outstanding was $405.0 million and our shareholders' equity was $404.9 million resulting in a debt-to-equity ratio of 1.0:1.0. Comprehensive Income Total comprehensive income consists of net income and other comprehensive income (loss). The Company’s other comprehensive income (loss) and accumulated other comprehensive income (loss) are composed of foreign currency translation adjustments. Concentration of Risk The Company generally serves individuals with limited access to other sources of consumer credit such as banks, credit unions, other consumer finance businesses and credit card lenders. During the year ended March 31, 2021, the Company operated in sixteen states in the United States. For the years ended March 31, 2021, 2020, and 2019, total revenue within the Company's four largest states (Texas, Georgia, Tennessee, and South Carolina) accounted for approximately 53%, 56% and 57%, respectively, of the Company's total revenues. The Company maintains amounts in bank accounts which, at times, may exceed federally insured limits. The Company has not experienced losses in such accounts, which are maintained with large domestic banks. Management believes the Company’s exposure to credit risk is minimal for these accounts. Advertising Costs Advertising costs are expensed when incurred. Advertising costs were approximately $17.2 million, $24.3 million, and $22.5 million for fiscal years 2021, 2020, and 2019, respectively. Recently Adopted Accounting Standards Measurement of Credit Losses on Financial Instruments ASU 2016-13 (and all subsequent ASUs on this topic) introduce the CECL model, a new credit loss methodology, replacing multiple existing impairment methods in current GAAP, which generally require that a loss be incurred before it is recognized. The amendments in this ASU require loss estimates be determined over the lifetime of the asset and broaden the information that an entity must consider in developing its expected credit losses. The ASU does not specify a method for measuring expected credit losses and allows an entity to apply methods that reasonably reflect its expectations of the credit loss estimate based on the entity’s size, complexity, and risk profile. In addition, the disclosures of credit quality indicators in relation to the amortized cost of financing receivables, a current disclosure requirement, are further disaggregated by year of origination. The Company adopted this ASU (and all subsequent ASUs on this topic) as of April 1, 2020 using the modified retrospective approach. The adoption of this pronouncement resulted in the recognition of a $28.6 million increase in the allowance for credit losses on our opening balance sheet as of April 1, 2020, with a corresponding net-of-tax $21.2 million reduction in retained earnings and a $7.4 million increase to deferred income taxes, net. Recently Issued Accounting Standards Not Yet Adopted We reviewed all newly issued accounting pronouncements and concluded that they are either not applicable to our business or are not expected to have a material effect on the consolidated financial statements as a result of future adoption. |
Allowance for Credit Losses and
Allowance for Credit Losses and Credit Quality Information | 12 Months Ended |
Mar. 31, 2021 | |
Receivables [Abstract] | |
Allowance for Credit Losses and Credit Quality Information | Allowance for Credit Losses and Credit Quality Information The following is a summary of gross loans receivable by Customer Tenure as of: Customer Tenure March 31, 2021 0 to 5 months $ 92,378,097 6 to 17 months 106,742,121 18 to 35 months 169,361,910 36 to 59 months 130,655,627 60+ months 597,292,495 Tax advance loans 8,316,011 Total gross loans $ 1,104,746,261 During the first quarter of fiscal 2021, we adopted ASU 2016-13, which replaces the incurred loss methodology for determining our provision for credit losses and allowance for credit losses with an expected loss methodology that is referred to as the CECL model, using the modified retrospective approach. Upon adoption, the total allowance for credit losses increased by $28.6 million, with no impact to the consolidated statement of operations. Based on the Company’s loan products, the purpose and the term, current payment performance is used to assess the capability of the borrower to repay contractual obligations of the loan agreements as scheduled. Current payment performance is monitored by management on a daily basis. On an as needed basis, qualitative information may be taken into consideration if new information arises related to the customer’s ability to repay the loan. The Company’s payment performance buckets are as follows: current, 30-60 days past due, 61-90 days past due, 91 days or more past due. The following tables provide a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at March 31, 2021: Term Loans By Origination Loans Up to Between Between Between Between More than Total Current $ 970,526,682 $ 45,769,052 $ 2,102,732 $ 154,890 $ 14,444 $ 831 $ 1,018,568,631 30 - 60 days past due 21,862,634 2,011,261 153,417 21,426 3,500 2,069 24,054,307 61 - 90 days past due 18,039,010 1,208,936 88,119 11,800 571 — 19,348,436 91 or more days past due 31,126,328 3,120,210 183,434 14,028 14,708 168 34,458,876 Total $ 1,041,554,654 $ 52,109,459 $ 2,527,702 $ 202,144 $ 33,223 $ 3,068 $ 1,096,430,250 Term Loans By Origination Tax advance loans Up to Between Between Between Between More than Current $ 7,583,075 $ 9,360 $ — $ — $ — $ — $ 7,592,435 30 - 60 days past due 686,667 1,423 — — — — 688,090 61 - 90 days past due — — 321 — — — 321 91 or more days past due — 34,509 656 — — — 35,165 Total $ 8,269,742 $ 45,292 $ 977 $ — $ — $ — $ 8,316,011 Total gross loans $ 1,104,746,261 The following tables provide a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at March 31, 2021: Term Loans By Origination Loans Up to Between Between Between Between More than Total Current $ 948,353,853 $ 39,661,944 $ 1,522,148 $ 83,073 $ 1,790 $ 831 $ 989,623,639 30 - 60 days past due 29,300,148 1,872,816 72,187 1,322 — — 31,246,473 61 - 90 days past due 23,075,264 1,363,196 75,343 567 — — 24,514,370 91 or more days past due 40,825,388 9,211,503 858,024 117,183 31,433 2,237 51,045,768 Total $ 1,041,554,653 $ 52,109,459 $ 2,527,702 $ 202,145 $ 33,223 $ 3,068 $ 1,096,430,250 Term Loans By Origination Tax advance loans Up to Between Between Between Between More than Total Current $ 7,583,075 $ — $ — $ — $ — $ — $ 7,583,075 30 - 60 days past due 686,667 — — — — — 686,667 61 - 90 days past due — — — — — — — 91 or more days past due — 45,292 977 — — — 46,269 Total $ 8,269,742 $ 45,292 $ 977 $ — $ — $ — $ 8,316,011 Total gross loans $ 1,104,746,261 The allowance for credit losses is applied to amortized cost, which is defined as the amount at which a financing receivable is originated, and net of deferred fees and costs, collection of cash, and charge-offs. Amortized cost also includes interest earned but not collected. Credit Risk is inherent in the business of extending loans to borrowers and is continuously monitored by management and reflected within the allowance for credit losses for loans. The allowance for credit losses is an estimate of expected losses inherent within the Company’s gross loans receivable portfolio. In estimating the allowance for credit losses, loans with similar risk characteristics are aggregated into pools and collectively assessed. The Company’s loan products have generally the same terms therefore the Company looked to borrower characteristics as a way to disaggregate loans into pools sharing similar risks. In determining the allowance for credit losses, the Company examined four borrower risk metrics as noted below. 1. Borrower type 2. Active months 3. Prior loan performance 4. Customer Tenure To determine how well each metric predicts default risk the Company uses loss rate data over an observation period of twelve months at the loan level.The information value was then calculated for each metric. From this analysis management determined the metric that had the strongest predictor of default risk was Customer Tenure. The Customer Tenure buckets used in the allowance for credit loss calculation are: 1. 0 to 5 months 2. 6 to 17 months 3. 18 to 35 months 4. 36 to 59 months 5. 60+ months Management will continue to monitor this credit metric on a quarterly basis. Management estimates an allowance for each Customer Tenure bucket by performing a historical migration analysis of loans in that bucket for the twelve most recent historical twelve-month migration periods, adjusted for seasonality. All loans that are greater than 90 days past due on a recency basis and not written off as of the reporting date are reserved for at 100% of the outstanding balance, net of a calculated Rehab Rate. Management considers whether current credit conditions might suggest a change is needed to the allowance for credit losses by monitoring trends in 60-day delinquencies, FICO scores and average loan size as compared to metrics in the historical migration period. Due to the short term nature of the loan portfolio, forecasted changes in macroeconomic variables such as unemployment do not have a significant impact on loans outstanding at the end of a particular reporting period. Therefore, management develops a reasonable and supportable forecast of losses by comparing the most recent 6-month loss curves as compared to historical loss curves to see if there are significant changes in borrower behavior that may indicate the historical migration rates should be adjusted. If an adjustment is made as a result of the forecast, then the Company has elected to immediately revert back to historical experience past the forecast period. The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at March 31, 2021: Days Past Due - Recency Basis Customer Tenure Current 30 - 60 61 - 90 Over 90 Total Past Due Total Loans 0 to 5 months $ 72,702,970 $ 4,799,102 $ 5,680,380 $ 9,195,642 $ 19,675,124 $ 92,378,094 6 to 17 months 94,466,209 3,187,347 2,798,411 6,290,155 12,275,913 106,742,122 18 to 35 months 158,217,605 3,570,696 2,592,402 4,981,208 11,144,306 169,361,911 36 to 59 months 123,542,346 2,432,489 1,753,291 2,927,501 7,113,281 130,655,627 60+ months 569,639,500 10,064,674 6,523,952 11,064,370 27,652,996 597,292,496 Tax advance loans 7,592,435 688,090 321 35,165 723,576 8,316,011 Total gross loans 1,026,161,065 24,742,398 19,348,757 34,494,041 78,585,196 1,104,746,261 Unearned interest, insurance and fees (259,492,219) (6,256,776) (4,892,850) (8,722,739) (19,872,365) (279,364,584) Total net loans $ 766,668,846 $ 18,485,622 $ 14,455,907 $ 25,771,302 $ 58,712,831 $ 825,381,677 Percentage of period-end gross loans receivable 2.2% 1.8% 3.1% 7.1% The following tables provide a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at March 31, 2021: Days Past Due - Contractual Basis Loans Current 30 - 60 61 - 90 Over 90 Total Past Due Total Loans 0 to 5 months $ 70,532,439 $ 5,245,878 $ 6,019,264 $ 10,580,514 $ 21,845,656 $ 92,378,095 6 to 17 months 90,679,304 3,936,937 3,267,446 8,858,434 16,062,817 106,742,121 18 to 35 months 153,922,334 4,471,202 3,488,629 7,479,745 15,439,576 169,361,910 36 to 59 months 120,168,698 3,229,253 2,337,625 4,920,052 10,486,930 130,655,628 60+ months 554,320,865 14,363,203 9,401,406 19,207,022 42,971,631 597,292,496 Tax advance loans 7,583,075 686,667 — 46,269 732,936 8,316,011 Total gross loans $ 997,206,715 $ 31,933,140 $ 24,514,370 $ 51,092,036 $ 107,539,546 $ 1,104,746,261 Unearned interest, insurance and fees $ (252,170,339) $ (8,075,147) $ (6,199,113) $ (12,919,985) $ (27,194,245) $ (279,364,584) Total net loans $ 745,036,376 $ 23,857,993 $ 18,315,257 $ 38,172,051 $ 80,345,301 $ 825,381,677 Percentage of period-end gross loans receivable 2.9% 2.2% 4.6% 9.7% The Company elected not to record an allowance for credit losses for accrued interest as outlined in ASC 326-20-30-5A. Loans are placed on nonaccrual status when management determines that the full payment of principal and collection of interest according to contractual terms is no longer likely. The accrual of interest is discontinued when a loan is 61 days or more past the contractual due date. When the interest accrual is discontinued, all unpaid accrued interest is reversed against interest income. While a loan is on nonaccrual status, interest revenue is recognized only when a payment is received. Once a loan moves to nonaccrual status, it remains in nonaccrual status until it is paid out, charged off or refinanced. During the three months ended March 31, 2021, the Company reversed a total of $6.2 million of unpaid accrued interest against interest income. During the twelve months ended March 31, 2021, the Company reversed a total of $22.4 million of unpaid accrued interest against interest income. The following table presents the amortized cost basis of loans on nonaccrual status as of the beginning of the reporting period and the end of the reporting period and the amortized cost basis of nonaccrual loans without related expected credit loss. It also shows year-to-date interest income recognized on nonaccrual loans: Nonaccrual Financial Assets Customer Tenure As of March 31, 2021 As of March 31, 2020 Financial Assets 61 Days or More Past Due, Not on Nonaccrual Status Nonaccrual Financial Assets With No Allowance as of March 31, 2021 Interest Income 0 to 5 months $ 17,191,922 $ 26,040,593 $ — $ — $ 1,705,371 6 to 17 months 13,211,641 17,466,450 — — 2,433,144 18 to 35 months 12,088,377 13,723,295 — — 2,195,160 36 to 59 months 8,161,951 10,071,288 — — 1,609,059 60+ months 31,925,232 44,293,545 — — 6,747,722 Tax advance loans 46,269 41,573 — — — Unearned interest, insurance and fees (20,894,036) (28,510,140) Total $ 61,731,356 $ 83,126,604 $ — $ — $ 14,690,456 The following is a summary of the changes in the allowance for credit losses for the years ended March 31, 2021, 2020, and 2019: 2021 2020 2019 Balance at beginning of period $ 96,487,856 81,519,624 66,088,139 Impact of ASC 326 adoption 28,628,368 — — Provision for loan losses 86,244,714 181,730,182 148,426,578 Loan losses (141,270,125) (183,439,199) (148,308,199) Recoveries 21,631,475 16,677,249 15,313,106 Balance at end of period $ 91,722,288 96,487,856 81,519,624 Under the prior incurred loss methodology, loss contingencies were evaluated as: probable, reasonably possible, or remote. If, at the date of financial statement presentation, information was available that indicated an asset had been impaired and the amount of loss could be reasonably estimated, then an allowance for that loss could be recorded. Recording an allowance for a loss that was considered reasonably possible or remote was not permitted. With the adoption of ASC 326, the Company considers the lifetime potential for losses at the point of origination and records an allowance for that potential, at that point in time, removing the necessity of differentiation between the three loss contingency concepts and impairment. The following disclosures are presented under previously applicable GAAP. March 31, 2020 Loans individually Loans collectively Total Gross loans in bankruptcy, excluding contractually delinquent $ 5,165,752 — 5,165,752 Gross loans contractually delinquent 70,719,727 — 70,719,727 Loans not contractually delinquent and not in bankruptcy — 1,133,985,887 1,133,985,887 Gross loan balance 75,885,479 1,133,985,887 1,209,871,366 Unearned interest and fees (16,848,762) (292,131,962) (308,980,724) Net loans 59,036,717 841,853,925 900,890,642 Allowance for loan losses (54,090,509) (42,397,347) (96,487,856) Loans, net of allowance for loan losses $ 4,946,208 799,456,578 804,402,786 The average net balance of impaired loans was $57.2 million, and $47.0 million, respectively, for the years ended March 31, 2020, and 2019. It is not practicable to compute the amount of interest earned on impaired loans, nor is it practicable to compute the interest income recognized using the cash-basis method during the period such loans were impaired. The following is an assessment of the credit quality for March 31, 2020: Credit risk Consumer loans- non-bankrupt accounts $ 1,203,552,152 Consumer loans- bankrupt accounts 6,319,214 Total gross loans 1,209,871,366 Consumer credit exposure Credit risk profile based on payment activity, performing 1,104,130,714 Contractual non-performing, 61 days or more delinquent (1) 105,740,652 Total gross loans 1,209,871,366 Credit risk profile based on customer type New borrower 124,800,193 Former borrower 127,108,125 Refinance 935,448,882 Delinquent refinance 22,514,166 Total gross loans $ 1,209,871,366 _______________________________________________________ (1) Loans in non-accrual status The following is a summary of the past due receivables as of: March 31, Contractual basis: 30-60 days past due $ 49,137,102 61-90 days past due 35,020,925 91 days or more past due 70,719,727 Total $ 154,877,754 Percentage of period-end gross loans receivable 12.8 % Recency basis: 30-60 days past due $ 48,206,910 61-90 days past due 28,450,942 91 days or more past due 50,669,837 Total $ 127,327,689 Percentage of period-end gross loans receivable 10.5 % |
Property and Equipment
Property and Equipment | 12 Months Ended |
Mar. 31, 2021 | |
Property, Plant and Equipment [Abstract] | |
Property and Equipment | Property and Equipment Property and equipment consist of: March 31, 2021 March 31, 2020 Land $ 100,443 100,443 Building and leasehold improvements 17,882,214 17,048,098 Furniture and equipment 54,735,353 51,376,746 72,718,010 68,525,287 Less accumulated depreciation and amortization (46,377,973) (43,764,179) Total $ 26,340,037 24,761,108 Depreciation expense was approximately $6.9 million, $7.1 million, and $6.6 million for the years ended March 31, 2021, 2020, and 2019, respectively. |
Intangible Assets
Intangible Assets | 12 Months Ended |
Mar. 31, 2021 | |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | |
Intangible Assets | Intangible Assets The following table provides the gross carrying amount and related accumulated amortization of definite-lived intangible assets: March 31, 2021 March 31, 2020 Gross Carrying Accumulated Net Intangible Asset Gross Carrying Accumulated Net Intangible Asset Cost of customer lists $ 54,777,749 (32,322,607) 22,455,142 $ 50,411,969 (27,215,464) 23,196,505 Value assigned to non-compete agreements 10,252,143 (9,169,768) 1,082,375 10,054,643 (8,802,671) 1,251,972 Total $ 65,029,892 (41,492,375) 23,537,517 $ 60,466,612 (36,018,135) 24,448,477 The estimated amortization expense for intangible assets for future years ended March 31 is as follows: $4.8 million for 2022; $4.2 million for 2023; $4.0 million for 2024; $3.7 million for 2025; $3.1 million for 2026; and an aggregate of $3.8 million for the years thereafter. |
Goodwill
Goodwill | 12 Months Ended |
Mar. 31, 2021 | |
Goodwill [Abstract] | |
Goodwill | Goodwill The following summarizes the changes in the carrying amount of goodwill for the years ended March 31, 2021 and 2020: 2021 2020 Balance at beginning of year: Goodwill $ 7,450,422 7,114,094 Accumulated goodwill impairment losses (79,631) (79,631) Goodwill, net $ 7,370,791 7,034,463 Goodwill acquired during the year $ — 336,328 Impairment losses — — Balance at end of year: Goodwill $ 7,450,422 7,450,422 Accumulated goodwill impairment losses (79,631) (79,631) Goodwill, net $ 7,370,791 7,370,791 The Company performed an annual impairment test during the fourth quarters of fiscal 2021 and 2020 and determined none of its recorded goodwill was impaired. |
Notes Payable
Notes Payable | 12 Months Ended |
Mar. 31, 2021 | |
Debt Disclosure [Abstract] | |
Notes Payable | Notes Payable Senior Notes Payable; Revolving Credit Facility At March 31, 2021, the Company's notes payable consisted of a $685.0 million senior revolving credit facility, which has an accordion feature permitting the maximum aggregate commitments to increase to $685.0 million provided that certain conditions are met. At March 31, 2021, $405.0 million was outstanding under the facility, not including a $300.0 thousand outstanding standby letter of credit related to workers compensation. To the extent that the letter of credit is drawn upon, the disbursement will be funded by the credit facility. There are no amounts due related to the letter of credit as of March 31, 2021. The letter of credit expires on December 31, 2021; however, it automatically extends for one year on the expiration date. Subject to a borrowing base formula, the Company may borrow at the rate of LIBOR plus an applicable margin between 3.5% and 4.5% based on certain EBITDA related metrics set forth in the revolving credit agreement, which will be determined and adjusted on a monthly basis with a minimum rate of 4.5%. The revolving credit facility has a commitment fee of 0.50% per annum on the unused portion of the commitment. Commitment fees on the unused portion of the borrowing totaled $1.3 million, $1.0 million, and $1.1 million for the years ended March 31, 2021, 2020, and 2019, respectively. Borrowings under the revolving credit facility mature on June 7, 2024. For the years ended March 31, 2021, 2020, and 2019 the Company’s effective interest rate, including the commitment fee, was 5.8%, 5.8%, and 6.7% respectively, and the unused amount available under the revolver at March 31, 2021 was $181.4 million. Substantially all of the Company's assets are pledged as collateral for borrowings under the revolving credit agreement. Debt Covenants The agreement governing the Company’s revolving credit facility contains affirmative and negative covenants, including covenants that restrict the ability of the Company and its subsidiaries to, among other things, incur or guarantee indebtedness, incur liens, pay dividends and repurchase or redeem capital stock, dispose of assets, engage in mergers and consolidations, make acquisitions or other investments, redeem or prepay subordinated debt, amend subordinated debt documents, make changes in the nature of its business, and engage in transactions with affiliates. The agreement also contains financial covenants, including (i) a minimum consolidated net worth of (a) $365.0 million through December 30, 2020 and (b) $325.0 million on and after December 31, 2020; (ii) a minimum fixed charge coverage ratio of (a) 2.25 to 1.0 for the fiscal quarters ending March 31, 2020, June 30, 2020 and September 30, 2020 and (b) 2.75 to 1.0 for each fiscal quarter thereafter; (iii) a maximum ratio of total debt to consolidated adjusted net worth of 2.0 to 1.0; and (iv) a maximum collateral performance indicator of 24% as of the end of each calendar month. The agreement allows the Company to incur subordinated debt that matures after the termination date for the revolving credit facility and that contains specified subordination terms, subject to limitations on amount imposed by the financial covenants under the agreement. The collateral performance indicator is equal to the sum of (a) a three-month rolling average rate of receivables at least sixty days past due and (b) an eight-month rolling average net charge-off rate. The Company was in compliance with these covenants at March 31, 2021 and does not believe that these covenants will materially limit its business and expansion strategy. The agreement contains events of default including, without limitation, nonpayment of principal, interest or other obligations, violation of covenants, misrepresentation, cross-default to other debt, bankruptcy and other insolvency events, judgments, certain ERISA events, actual or asserted invalidity of loan documentation, invalidity of subordination provisions of subordinated debt, certain changes of control of the Company, and the occurrence of certain regulatory events (including the entry of any stay, order, judgment, ruling or similar event related to the Company’s or any of its subsidiaries’ originating, holding, pledging, collecting or enforcing its eligible finance receivables that is material to the Company or any subsidiary) which remains unvacated, undischarged, unbonded or unstayed by appeal or otherwise for a period of 60 days from the date of its entry and is reasonably likely to cause a material adverse change. Debt Maturities As of March 31, 2021, the aggregate annual maturities of the notes payable for each of the five fiscal years subsequent to March 31, 2021 were as follows: 2022 $ — 2023 — 2024 — 2025 405,007,500 2026 — Total future debt payments $ 405,007,500 |
Insurance and Other Income
Insurance and Other Income | 12 Months Ended |
Mar. 31, 2021 | |
Insurance Commissions and other income [Abstract] | |
Insurance and Other Income | Insurance and Other Income Insurance and other income for the years ending March 31, 2021, 2020, and 2019 consist of: 2021 2020 2019 Insurance revenue $ 44,214,454 50,360,730 45,182,596 Tax return preparation revenue 18,098,087 20,936,447 21,454,117 Auto club membership revenue 7,863,145 6,254,748 4,452,018 Other 4,244,079 4,150,319 4,299,917 Insurance and other income $ 74,419,765 81,702,244 75,388,648 The Company has a wholly-owned, captive insurance subsidiary that reinsures a portion of the credit insurance sold in connection with loans made by the Company. Certain coverages currently sold by the Company on behalf of the unaffiliated insurance carrier are ceded by the carrier to the captive insurance subsidiary, providing the Company with an additional source of income derived from the earned reinsurance premiums. Insurance premiums are ceded to the reinsurance subsidiary as written and revenue is recognized over the life of the related insurance contracts. As of March 31, 2021, 2020, and 2019, the amount of net written premiums by the reinsurance subsidiary were $5.9 million, $6.6 million, and $5.6 million, respectively, and the amount of earned premiums were $6.0 million, $6.2 million, and $5.7 million, respectively. |
Non-filing Insurance
Non-filing Insurance | 12 Months Ended |
Mar. 31, 2021 | |
Non-file Insurance [Abstract] | |
Non-filing Insurance | Non-filing Insurance The Company maintains non-filing insurance coverage with an unaffiliated insurance company. The following is a summary of the non-filing insurance activity for the years ended March 31, 2021, 2020, and 2019: 2021 2020 2019 Insurance premiums written $ 7,072,647 8,251,927 6,164,871 Recoveries on claims paid $ 959,620 1,001,288 996,482 Claims paid $ 5,223,484 7,570,126 6,553,271 |
Leases
Leases | 12 Months Ended |
Mar. 31, 2021 | |
Leases [Abstract] | |
Leases | Leases Accounting Policies and Matters Requiring Management's Judgment When determining the economic life of a lease the Company adopts a convention of applying an economic life equal to the useful life as specified in its accounting policy. Refer to Note 1, “Property and Equipment,” in this Annual Report on Form 10-K for a description of the Company's accounting policy regarding useful lives. The Company uses its effective annual interest rate as the discount rate when evaluating leases under Topic 842. Management applies its effective annual interest rate to leases entered for the entirety of the subsequent year. For example, fiscal 2020’s annual effective interest rate of 5.8% will be used in the determination of lease type as well as the discount rate when calculating the present value of lease payments for all leases entered into in fiscal 2020 or until a new annual effective interest rate is available for application. Based on its historical practice, the Company believes it is reasonably certain to exercise a given option associated with a given office space lease. Therefore, the Company classifies all lease options for office space as “reasonably certain” unless it has specific knowledge to the contrary for a given lease. The Company does not believe it is reasonably certain to exercise any options associated with its office equipment leases. Periodic Disclosures The Company's leases consist of real estate leases for office space as well as office equipment leases, all of which were classified as operating at March 31, 2021. Both the branch real estate and office equipment leases range from three years to five years, and generally contain options to extend which mirror the original terms of the lease. The following table reports information about the Company's lease cost for the years ended March 31, 2021 and 2020: 2021 2020 Lease Cost Operating lease cost $ 27,977,226 $ 26,244,323 Short-term lease cost 1,800 4,500 Variable lease cost 3,621,748 3,376,275 Total lease cost $ 31,600,774 $ 29,625,098 The following table reports other information about the Company's leases for years ended March 31, 2021 and 2020: 2021 2020 Other Lease Information Cash paid for amounts included in the measurement of lease liabilities $ 27,559,260 $ 25,618,886 Right-of-use assets obtained in exchange for new operating lease liabilities $ 12,482,167 $ 36,826,045 Weighted average remaining lease term — operating leases 7.3 years 8.4 years Weighted-average discount rate — operating leases 6.3 % 6.7 % The following table reports information about the maturity of the Company's operating leases as of March 31, 2021: Operating lease liability maturity analysis FY2022 25,697,140 FY2023 21,366,591 FY2024 17,262,768 FY2025 12,608,028 FY2026 8,874,883 Thereafter 31,311,884 Total undiscounted lease liability $ 117,121,294 Imputed interest 25,403,219 Total discounted lease liability $ 91,718,075 The Company had no leases with related parties at March 31, 2021 or 2020. |
Income Taxes
Income Taxes | 12 Months Ended |
Mar. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the TCJA. The TCJA included significant changes to existing tax law, including a permanent reduction to the U.S. federal corporate income tax rate from 35% to 21%, a one-time repatriation tax on deferred foreign income (“Transition Tax”), deductions, credits and business-related exclusions. The impact of changes in federal tax rates on deferred tax amounts and the effect of the Transition Tax are significant unusual or infrequent events which are recognized as discrete items in the Company’s income tax expense in the period in which the event occurs. The Company recorded a $10.5 million increase in tax expense related to the net impact of revaluing the U.S. deferred tax assets and liabilities in the third quarter of fiscal 2018. An adjustment was made in the third quarter of fiscal 2019 to record an $850.0 thousand tax benefit related to the revaluing of the U.S. deferred tax assets and liabilities due to additional analysis and change in estimate from the original calculation. The Company also recorded an increase in tax expense of $4.9 million related to the foreign Transition Tax during the final quarter of fiscal 2018. Because of the Transition Tax, the Company's tax basis was greater than its book basis. The recognition of the basis difference upon the sale of the Mexican operations in fiscal 2019 created a capital loss that the Company does not believe will be recognized in the carryforward period; therefore, a full tax valuation allowance was recorded against the recognized loss carryforward. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted in response to the COVID-19 pandemic. The CARES Act, among other things, expands current benefits of net operating losses and increases the allowable business interest deduction under Section 163(j). The CARES Act did not have a material impact on the Company's income tax position. Income tax expense (benefit) from continuing operations consists of: Current Deferred Total Year ended March 31, 2021 Continuing Operations- Federal $ 16,443,592 4,077,609 20,521,201 Continuing Operations- State and local 1,025,645 1,573,753 2,599,398 $ 17,469,237 5,651,362 23,120,599 Year ended March 31, 2020 Continuing Operations- Federal $ 3,307,872 (224,604) 3,083,268 Continuing Operations- State and local 2,871,179 797,518 3,668,697 $ 6,179,051 572,914 6,751,965 Year ended March 31, 2019 Continuing Operations- Federal $ 20,508,247 (1,833,943) 18,674,304 Continuing Operations- State and local (871,439) (1,821,808) (2,693,247) $ 19,636,808 (3,655,751) 15,981,057 The differences between income taxes expected at the U.S. federal statutory income tax rate of 21% and the reported income tax expense from continuing operations for March 31, 2021, 2020 and 2019 are summarized as follows: 2021 2020 2019 Expected income tax $ 23,394,720 7,330,983 18,874,500 Increase (reduction) in income taxes resulting from: State tax (excluding state tax credits), net of federal benefit 2,053,524 3,398,271 1,576,915 Federal tax credits (net) (1,173,435) (7,616,236) — State tax credits — (500,000) (3,704,580) Revalue deferred tax assets and liabilities — — (852,523) Uncertain tax positions (2,107,263) (167,455) (183,929) Nondeductible penalties 8,274 4,562,830 2,210 Executive compensation limitation under Section 162(m) 1,203,203 1,305,975 37,457 Excess tax benefits related to equity compensation (996,769) (612,987) (287,703) Prior year adjustments (30,953) (672,358) 106,075 Other, net 769,298 (277,058) 412,635 $ 23,120,599 6,751,965 15,981,057 The differences between income taxes expected at the U.S. federal statutory income tax rate of 21% and the reported income tax expense from discontinued operations for March 31, 2021, 2020 and 2019 are summarized as follows: 2021 2020 2019 Expected income tax $ — — 491,783 Increase (reduction) in income taxes resulting from: Foreign income adjustments — — 187,974 Other, net — — (53,174) $ — — 626,583 The tax effects of temporary differences from continuing operations that give rise to significant portions of the deferred tax assets and deferred tax liabilities at March 31, 2021 and 2020 are presented below: 2021 2020 Deferred tax assets: Allowance for credit losses $ 22,908,670 23,900,236 Unearned insurance commissions 10,080,766 9,964,655 Accrued expenses primarily related to employee benefits 13,676,701 12,730,245 Reserve for uncollectible interest 645,113 1,205,082 Lease liability 22,231,591 25,309,841 Foreign tax credit carryforward 3,254,926 3,254,926 Capital loss carryforward 7,928,184 7,784,059 State net operating loss carryforwards 78,358 387,558 Gross deferred tax assets 80,804,309 84,536,602 Less valuation allowance (11,184,384) (11,040,259) Net deferred tax assets 69,619,925 73,496,343 Deferred tax liabilities: Fair value adjustment for loans receivable (12,362,590) (14,065,135) Property and equipment (5,902,421) (5,097,147) Intangible assets (243,574) (925,319) Deferred net loan origination costs (1,268,653) (1,664,486) Prepaid expenses (1,412,337) (1,185,759) Right-of-use asset (21,826,178) (25,045,690) Other (1,611,430) (2,254,822) Gross deferred tax liabilities (44,627,183) (50,238,358) Deferred income taxes, net $ 24,992,742 23,257,985 At March 31, 2021, the Company had state net operating loss carryforwards of approximately $2.2 million. A deferred tax asset of approximately $0.1 million has been recorded to reflect the benefit of these losses that the Company expects to be recognized. Approximately $1,000 of the state net operating loss carryforward will expire in 2025 with the remaining carryforward expiring between 2036 and 2039. The valuation allowance for deferred tax assets increased by $144,125 for the year ended March 31, 2021 when compared to March 31, 2020. The valuation allowance at March 31, 2021 and 2020 was $11.2 million and $11.0 million, respectively. The valuation allowance against the total deferred tax assets as of March 31, 2021 consisted of $1,274 related to state of Colorado net operating loss carryforwards in the amount of $54,318, which expire in 2025, a foreign tax credit carryforward of $3.3 million arising in relation to the Section 965 calculation ("Transition Tax") during fiscal 2018 which expires in 2028, and $7.9 million related to the $37.1 million capital loss carryforward from the sale of the Mexican operations in fiscal 2019 which expires in 2024 and $0.7 million related to the sale of the former headquarters building which expires in 2026. The Company does not expect to generate enough foreign source income or capital gains in future tax years to realize these tax attributes. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversals of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. In order to fully realize the deferred tax asset, the Company will need to generate future taxable income of the appropriate character prior to the expiration of the deferred tax assets governed by the tax code. Based upon the level of historical taxable income and projections for future taxable income over the periods in which the related temporary differences are deductible, management believes it is more likely than not the Company will realize the benefits of these deductible differences, net of the existing valuation allowances at March 31, 2021. The amount of the deferred tax asset considered realizable, however, could be reduced in the near term if estimates of future taxable income during the carryforward period are reduced. As of March 31, 2021, 2020, and 2019, the Company had $3.1 million, $5.8 million, and $5.8 million of total gross unrecognized tax benefits including interest, respectively. Of these totals, approximately $2.6 million, $5.2 million, and $5.4 million, respectively, represents the amount of net unrecognized tax benefits that are permanent in nature and, if recognized, would affect the annual effective tax rate. A reconciliation of the beginning and ending amount of unrecognized tax benefits at March 31, 2021, 2020, and 2019 are presented below: 2021 2020 2019 Unrecognized tax benefit balance beginning of year $ 4,351,811 4,043,623 6,946,229 Gross increases for tax positions of current year 36,541 246,725 54,025 Gross increases (decreases) for tax positions of prior years — 786,674 (138,405) Settlements with tax authorities (1,968,702) — (1,356,714) Lapse of statute of limitations (608,406) (725,211) (1,461,512) Unrecognized tax benefit balance end of year $ 1,811,244 4,351,811 4,043,623 At March 31, 2021, approximately $0.7 million of gross unrecognized tax benefits are expected to be resolved during the next 12 months through settlements with taxing authorities or the expiration of the statute of limitations. The Company’s continuing practice is to recognize interest and penalties related to income tax matters in income tax expense. As of March 31, 2021, 2020, and 2019, the Company had $1.2 million, $1.4 million, and $1.8 million accrued for gross interest, respectively, of which $0.3 million, $(0.1) million, and $1.1 million represented the current period expense for the periods ended March 31, 2021, 2020, and 2019. The Company is subject to U.S. income tax, as well as various other state and local jurisdictions. With the exception of a few states, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2016, although carryforward attributes that were generated prior to 2016 may still be adjusted upon examination by the taxing authorities if they either have been or will be used in a future period. |
Earnings Per Share
Earnings Per Share | 12 Months Ended |
Mar. 31, 2021 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | Earnings Per Share The following is a reconciliation of the numerators and denominators of the basic and diluted EPS from continuing operations calculations: For the year ended March 31, 2021 Income Shares Per Share Basic EPS Income from continuing operations available to common shareholders $ 88,282,828 6,493,898 $ 13.59 Effect of dilutive securities options and restricted stock — 178,212 Diluted EPS Income from continuing operations available to common shareholders including dilutive securities $ 88,282,828 6,672,110 $ 13.23 For the year ended March 31, 2020 Income Shares Per Share Amount Basic EPS Income from continuing operations available to common shareholders $ 28,157,478 7,688,242 $ 3.66 Effect of dilutive securities options and restricted stock — 264,658 Diluted EPS Income from continuing operations available to common shareholders including dilutive securities $ 28,157,478 7,952,900 $ 3.54 For the year ended March 31, 2019 Income Shares Per Share Amount Basic EPS Income from continuing operations available to common shareholders $ 73,897,515 8,994,036 $ 8.22 Effect of dilutive securities options and restricted stock — 210,341 Diluted EPS Income from continuing operations available to common shareholders including dilutive securities $ 73,897,515 9,204,377 $ 8.03 Options to purchase 608,087, 656,347, and 592,947 shares of common stock at various prices were outstanding during the years ended March 31, 2021, 2020, and 2019, respectively, but were not included in the computation of diluted EPS because the option exercise price was antidilutive. |
Benefit Plans
Benefit Plans | 12 Months Ended |
Mar. 31, 2020 | |
Share-based Payment Arrangement [Abstract] | |
Benefit Plans | Benefit Plans Retirement Plan The Company provides a defined contribution employee benefit plan (401(k) plan) covering full-time employees, whereby employees can invest up to the maximum designated for that year. The Company matches 50% of each employee's contributions up to the first 6% of the employee's eligible compensation, providing a maximum employer contribution of 3% of compensation. The Company's expense under this plan was $1.6 million, $1.6 million, and $1.5 million, for the years ended March 31, 2021, 2020, and 2019, respectively. Supplemental Executive Retirement Plan The Company has instituted two supplemental executive retirement plans, which are non-qualified executive benefit plans in which the Company agrees to pay certain executives additional benefits in the future, usually at retirement, in return for continued employment by the executives. The SERPs are unfunded plans, and, as such, there are no specific assets set aside by the Company in connection with the establishment of the plans. The executives have no rights under the agreements beyond those of a general creditor of the Company. For the years ended March 31, 2021, 2020, and 2019, contributions of $0.55 million, $0.58 million, and $0.65 million, respectively, were charged to expense related to the SERP. The unfunded liability, which is included as a component of accounts payable and accrued expenses in the Company's Consolidated Balance Sheets was $6.4 million and $6.8 million as of March 31, 2021 and 2020, respectively. For the three years presented, the unfunded liability was estimated using the following assumptions: an annual salary increase of 3.5% for all 3 years; a discount rate of 6.0% for all 3 years; and a retirement age of 65. Executive Deferred Compensation Plan The Company has an Executive Deferral Plan. Eligible executives and directors may elect to defer all or a portion of their incentive compensation to be paid under the Executive Deferral Plan. As of March 31, 2021 and 2020 no executive or director had deferred compensation under this plan. Stock Incentive Plans The Company has a 2008 Stock Option Plan, a 2011 Stock Option Plan, and a 2017 Stock Incentive Plan for the benefit of certain directors, officers, and key employees. Under these plans, a total of 3,350,000 shares of authorized common stock have been reserved for issuance pursuant to grants approved by the Compensation and Stock Option Committee of the Board of Directors. Stock options granted under these plans have a maximum duration of ten years, may be subject to certain vesting requirements, which are generally three to six years for officers, non-employee directors, and key employees, and are priced at the market value of the Company's common stock on the option's grant date. At March 31, 2021 there were a total of 170,377 shares of common stock available for grant under the plans. Stock-based compensation is recognized as provided under FASB ASC Topic 718-10 and FASB ASC Topic 505-50. FASB ASC Topic 718-10 requires all share-based payments to employees, including grants of employee stock options, to be recognized as compensation expense over the requisite service period (generally the vesting period) in the consolidated financial statements based on their grant date fair values. The Company has applied the Black-Scholes valuation model in determining the grant date fair value of the stock option awards. Compensation expense is recognized only for those options expected to vest. Long-term Incentive Program and Non-Employee Director Awards On October 15, 2018, the Compensation Committee and Board approved and adopted a new long-term incentive program that seeks to motivate and reward certain employees and to align management’s interest with shareholders’ by focusing executives on the achievement of long-term results. The program is comprised of four components: Service Options, Performance Options, Restricted Stock, and Performance Shares. Pursuant to this program, the Compensation Committee approved certain grants of Service Options, Performance Options, Restricted Stock and Performance Shares under the World Acceptance Corporation 2011 Stock Option Plan and the World Acceptance Corporation 2017 Stock Incentive Plan to certain employee directors, vice presidents of operations, vice presidents, senior vice presidents, and executive officers. Separately, the Compensation Committee approved certain grants of Service Options and Restricted Stock to certain of the Company’s non-employee directors. Under the long-term incentive program, up to 100% of the shares of restricted stock subject to the Performance Shares shall vest, if at all, based on the achievement of two trailing earnings per share performance targets established by the Compensation Committee that are based on earnings per share (measured at the end of each calendar quarter, commencing with the calendar quarter ending September 30, 2019) for the previous four calendar quarters. The Performance Shares are eligible to vest over the Performance Share Measurement Period and subject to each respective employee’s continued employment at the Company through the last day of the applicable Performance Share Measurement Period (or as otherwise provided under the terms of the applicable award agreement or applicable employment agreement). The Performance Share performance targets are set forth below. Trailing 4-Quarter EPS Targets for Restricted Stock Eligible for Vesting $16.35 40% $20.45 60% The Restricted Stock awards will vest in six equal annual installments, beginning on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The Service Options will vest in six equal annual installments, beginning on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Service Options shall have a 10-year term. The Performance Options shall fully vest if the Company attains the trailing earnings per share target over four consecutive calendar quarters occurring between September 30, 2018 and March 31, 2025 described below. Such performance target was established by the Compensation Committee and will be measured at the end of each calendar quarter commencing on September 30, 2019. The Performance Options are eligible to vest over the Option Measurement Period, subject to each respective employee’s continued employment at the Company through the last day of the Option Measurement Period or as otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Performance Options shall have a 10-year term. The Performance Option performance target is set forth below. Trailing 4-Quarter EPS Targets for Options Eligible for Vesting $25.30 100% Stock Options The weighted-average fair value at the grant date for options issued during the years ended March 31, 2021, 2020, and 2019 was $58.48, $57.69, and $53.50 per share, respectively. This fair value was estimated at grant date using the weighted-average assumptions listed below. 2021 2020 2019 Dividend yield 0 % 0 % 0 % Expected volatility 57.53 % 52.28 % 48.94 % Average risk-free interest rate 0.59 % 1.58 % 3.01 % Expected life 6.3 years 6.3 years 6.7 years The expected stock price volatility is based on the historical volatility of the Company’s stock for a period approximating the expected life. The expected life represents the period of time that options are expected to be outstanding after the grant date. The risk-free rate reflects the interest rate at grant date on zero coupon U.S. governmental bonds having a remaining life similar to the expected option term. Option activity for the year ended March 31, 2021 was as follows: Shares Weighted Weighted Aggregate Options outstanding, beginning of year 646,728 $ 88.30 Granted 38,473 109.30 Exercised (165,237) 74.25 Forfeited (18,666) 105.14 Expired (1,130) 103.75 Options outstanding, end of period 500,168 $ 93.89 6.29 $ 18,080,095 Options exercisable, end of period 213,095 $ 81.47 4.11 $ 10,300,232 The aggregate intrinsic value reflected in the table above represents the total pre-tax intrinsic value (the difference between the closing stock price on March 31, 2021 and the exercise price, multiplied by the number of in-the-money options) that would have been received by option holders had all option holders exercised their options as of March 31, 2021. This amount will change as the stock's market price changes. The total intrinsic value of options exercised during the years ended March 31, 2021, 2020, and 2019 was as follows: 2021 2020 2019 $9,996,167 $5,083,094 $4,433,495 As of March 31, 2021, total unrecognized stock-based compensation expense related to non-vested stock options amounted to approximately $8.4 million, which is expected to be recognized over a weighted-average period of approximately 3.7 years. Restricted Stock During fiscal 2021, the Company granted 52,735 shares of restricted stock (which are equity classified), to certain vice presidents, senior vice presidents, executive officers, and non-employee directors with a grant date weighted average fair value of $106.28 per share. During fiscal 2020, the Company granted 11,223 shares of restricted stock (which are equity classified) to certain vice presidents, senior vice presidents, executive officers, and non-employee directors with a grant date weighted average fair value of $90.23 per share. During fiscal 2019, the Company granted 760,420 shares of restricted stock (which are equity classified) to certain executive officers, with a grant date weighted average fair value of $101.61 per share. Compensation expense related to restricted stock is based on the number of shares expected to vest and the fair market value of the common stock on the grant date. The Company recognized compensation expense of $15.5 million, $23.4 million, and $13.6 million for the years ended March 31, 2021, 2020, and 2019, respectively, which is included as a component of general and administrative expenses in the Company's Consolidated Statements of Operations. As of March 31, 2021, there was approximately $27.2 million of unrecognized compensation cost related to unvested restricted stock awards, which is expected to be recognized over the next 2.5 years based on current estimates. A summary of the status of the Company’s restricted stock as of March 31, 2021 and changes during the year ended March 31, 2021, are presented below: Shares Weighted Average Fair Outstanding at March 31, 2020 705,254 $ 101.47 Granted during the period 52,735 106.28 Vested during the period (83,250) 101.17 Forfeited during the period (60,000) 100.79 Outstanding at March 31, 2021 614,739 $ 101.99 Total Stock-Based Compensation Total stock-based compensation included as a component of net income during the years ended March 31, 2021, 2020, and 2019 was as follows: 2021 2020 2019 Stock-based compensation related to equity classified units: Stock-based compensation related to stock options $ 3,804,674 5,522,883 3,991,967 Stock-based compensation related to restricted stock 15,476,603 23,429,277 13,643,343 Total stock-based compensation related to equity classified awards $ 19,281,277 28,952,160 17,635,310 |
Acquisitions
Acquisitions | 12 Months Ended |
Mar. 31, 2021 | |
Business Combinations [Abstract] | |
Acquisitions | Acquisitions The Company evaluates each set of assets and activities it acquires to determine if the set meets the definition of a business according to FASB ASC Topic 805-10-55. Acquisitions meeting the definition of a business are accounted for as a business combination while all other acquisitions are accounted for as an asset purchase. The following table sets forth the acquisition activity of the Company for the years ended March 31, 2021, 2020, and 2019: 2021 2020 2019 Number of branches acquired through business combinations — 38 17 Number of asset purchases 50 140 88 Total acquisitions 50 178 105 Purchase price $ 19,774,252 $ 61,555,973 $ 44,145,787 Tangible assets: Loans receivable, net 15,210,973 47,026,694 33,920,847 Property and equipment — 74,000 1,500 15,210,973 47,100,694 33,922,347 Excess of purchase prices over fair value of net tangible assets $ 4,563,279 $ 14,455,279 $ 10,223,440 Customer lists $ 4,365,779 $ 13,228,951 $ 9,688,440 Non-compete agreements 197,500 890,000 535,000 Goodwill — 336,328 — Acquisitions that are accounted for as business combinations typically result in one or more new branches. In such cases, the Company typically retains the existing employees and the branch location from the acquisition. The purchase price is allocated to the tangible assets and intangible assets acquired based upon their estimated fair values at the acquisition date. The remainder is allocated to goodwill. Acquisitions that are accounted for as asset purchases are typically limited to acquisitions of loan portfolios. The purchase price is allocated to the tangible assets and intangible assets acquired based upon their estimated fair values at the acquisition date. In an asset purchase, no goodwill is recorded. The Company’s acquisitions include tangible assets (generally loans and furniture and equipment) and intangible assets (generally non-compete agreements, customer lists, and goodwill), both of which are recorded at their fair values, which are estimated pursuant to the processes described below. Acquired loans are valued at the net loan balance. Given the short-term nature of these loans, generally eight months, and that these loans are priced at current rates, management believes the net loan balances approximate their fair value. Under CECL, acquired loans are included in the reserve calculations for all other loan types (excluding TALs). Management includes recent acquisition activity compared to historical activity when considering reasonable and supportable forecasts as it relates to assessing the adequacy of the allowance for expected credit losses. The Company did not acquire any loans that would qualify as PCD's during the period. Furniture and equipment are valued at the specific purchase price as agreed to by both parties at the time of acquisition, which management believes approximates their fair values. Non-compete agreements are valued at the stated amount paid to the other party for these agreements, which the Company believes approximates the fair value. Customer lists are valued with a valuation model that utilizes the Company’s historical data to estimate the value of any acquired customer lists. Customer lists are allocated at a branch level and are evaluated for impairment at a branch level when a triggering event occurs in accordance with FASB ASC Topic 360-10-05. If a triggering event occurs, the impairment loss to the customer list is generally the remaining unamortized customer list balance. In most acquisitions, the original fair value of the customer list allocated to an office is less than $100,000, and management believes that in the event a triggering event were to occur, the impairment loss to an unamortized customer list would be immaterial. The results of all acquisitions have been included in the Company’s Consolidated Financial Statements since the respective acquisition date. The pro forma impact of these branches as though they had been acquired at the beginning of the periods presented would not have a material effect on the results of operations as reported. |
Fair Value
Fair Value | 12 Months Ended |
Mar. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value | Fair Value Fair Value Disclosures The Company may carry certain financial instruments and derivative assets and liabilities at fair value on a recurring or nonrecurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. The Company determines the fair values of its financial instruments based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Fair value measurements are grouped in three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are: • Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities. • Level 2 – Inputs other than quoted prices that are observable for assets and liabilities, either directly or indirectly. These inputs include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are less active. • Level 3 – Unobservable inputs for assets or liabilities reflecting the reporting entity’s own assumptions. The Company’s financial instruments for the periods reported consist of the following: cash and cash equivalents, loans receivable, and senior notes payable. Fair value approximates carrying value for all of these instruments. Loans receivable are originated at prevailing market rates and have an average life of approximately 8 months. Given the short-term nature of these loans, they are continually repriced at current market rates. The Company’s revolving credit facility has a variable rate based on a margin over LIBOR and reprices with any changes in LIBOR. The Company also considered its creditworthiness in its determination of fair value. The carrying amounts and estimated fair values of financial assets and liabilities disclosed but not carried at fair value and their level within the fair value hierarchy are summarized below. March 31, 2021 March 31, 2020 Input Level Carrying Value Estimated Fair Value Carrying Value Estimated Fair Value ASSETS Cash and cash equivalents 1 $ 15,746,454 $ 15,746,454 $ 11,618,922 $ 11,618,922 Loans receivable, net 3 733,659,389 733,659,389 804,402,786 804,402,786 LIABILITIES Senior notes payable 3 405,007,500 405,007,500 451,100,000 451,100,000 The carrying amounts and estimated fair values of amounts the Company measures at fair value on a non-recurring basis, which are limited to the Company's assets held for sale, are summarized below: March 31, 2021 March 31, 2020 Input Level Carrying Value Estimated Fair Value Carrying Value Estimated Fair Value ASSETS Assets held for sale 2 $ 1,143,528 $ 1,143,528 $ 3,991,498 $ 3,991,498 The Company re-valued its corporate headquarters in Greenville, SC as of March 31, 2020 in conjunction with its reclassification of the related assets as held for sale. The revaluation resulted in an impairment loss of approximately $251,000, which is included as a component of other expense in the Company's Consolidated Statements of Operations. The observable inputs the Company used in its revaluation were the agreed-upon prices to sell the assets. There were no other significant assets or liabilities measured at fair value on a non-recurring basis as of March 31, 2021 and 2020. |
Quarterly Information (Unaudite
Quarterly Information (Unaudited) | 12 Months Ended |
Mar. 31, 2021 | |
Quarterly Financial Information Disclosure [Abstract] | |
Quarterly Information (Unaudited) | Quarterly Information (Unaudited) The following sets forth selected quarterly operating data: Fiscal 2021 Fiscal 2020 First Second Third Fourth First Second Third Fourth (Dollars in thousands, except for earnings per share data) Total revenues $ 123,867 124,441 130,946 146,280 138,441 141,573 146,996 163,018 Provision for credit losses 25,661 26,090 28,857 5,636 41,291 52,968 55,219 32,252 General and administrative expenses 71,608 75,293 77,875 77,411 81,776 78,452 90,558 96,707 Interest expense 5,562 5,893 7,305 6,940 4,403 6,328 7,130 8,035 Income tax expense 5,527 3,767 2,418 11,409 2,363 1,312 356 2,721 Net income (loss) $ 15,509 13,398 14,491 44,884 8,608 2,513 (6,267) 23,303 Net income (loss) per common share: Basic $ 2.26 2.01 2.32 7.25 1.01 0.32 (0.87) 3.23 Diluted $ 2.24 1.96 2.25 6.96 0.97 0.31 (0.87) 3.18 The Company's highest loan demand occurs generally from October through December, its third fiscal quarter. Loan demand is generally lowest and loan repayment highest from January to March, its fourth fiscal quarter. Consequently, the Company experiences significant seasonal fluctuations in its operating results and cash needs. Operating results from the Company's third fiscal quarter are generally lower than in other quarters and operating results for its fourth fiscal quarter are generally higher than in other quarters. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Mar. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies From time to time, the Company is involved in litigation matters relating to claims arising out of its operations in the normal course of business. Estimating an amount or range of possible losses resulting from litigation, government actions, and other legal proceedings is inherently difficult and requires an extensive degree of judgment, particularly where the matters involve indeterminate claims for monetary damages, may involve fines, penalties, or damages that are discretionary in amount, involve a large number of claimants or significant discretion by regulatory authorities, represent a change in regulatory policy or interpretation, present novel legal theories, are in the early stages of the proceedings, are subject to appeal or could result in a change in business practices. In addition, because most legal proceedings are resolved over extended periods of time, potential losses are subject to change due to, among other things, new developments, changes in legal strategy, the outcome of intermediate procedural and substantive rulings and other parties’ settlement posture and their evaluation of the strength or weakness of their case against us. For these reasons, we are currently unable to predict the ultimate timing or outcome of, or reasonably estimate the possible losses or a range of possible losses resulting from, the matters described above. Based on information currently available, the Company does not believe that any reasonably possible losses arising from currently pending legal matters will be material to the Company’s results of operations or financial conditions. However, in light of the inherent uncertainties involved in such matters, an adverse outcome in one or more of these matters could materially and adversely affect the Company’s financial condition, results of operations or cash flows in any particular reporting period. |
Assets Held for Sale
Assets Held for Sale | 12 Months Ended |
Mar. 31, 2021 | |
Property, Plant and Equipment [Abstract] | |
Assets Held for Sale | Assets Held for Sale In the fourth quarter of fiscal 2020 the Company moved its corporate headquarters from properties it owned outright in Greenville, South Carolina to leased office space in downtown Greenville, South Carolina. Under ASC 360-10, the properties met the criteria for classification as held for sale as of March 31, 2020. During the second quarter of fiscal 2021 the Company completed the sale of two of the three buildings held for sale, resulting in an aggregate loss of $37,579. The loss on sale of assets held for sale is included as a component of insurance income, net and other income in the Company's Consolidated Statement of Operations. The Company expects to complete the sale of the third, and final, building held for sale within the next twelve months. The following table reconciles the major classes of assets held for sale to the amounts presented in the Consolidated Balance Sheets: March 31, 2020 March 31, 2020 Assets held for sale: Property and equipment, net $ 1,143,528 $ 3,991,498 Total assets held for sale $ 1,143,528 $ 3,991,498 On August 3, 2018 the Company and its affiliates completed the sale of the Company's Mexico operating segment in its entirety. The Company sold all of the issued and outstanding capital stock and equity interest of WAC de Mexico and SWAC to the Purchasers, effective as of July 1, 2018, for a purchase price of approximately $44.4 million. Under the terms of the stock purchase agreement, we are obligated to indemnify the Purchasers for claims and liabilities relating to certain investigations of WAC de Mexico, SWAC, or the Sellers by the DOJ or the SEC that commenced prior to July 1, 2018. Additionally, the Company has provided limited ParaData systems and software training to the Purchasers, as requested. The Company has not and will not have any other involvement with the Mexico operating segment subsequent to the sale's effective date. The following table reconciles the major classes of line items constituting pre-tax income of discontinued operations to the amounts presented in the Consolidated Statements of Operations: Year ended March 31, 2021 2020 2019 Revenues $ — $ — $ 9,693,367 Provision for loan losses — — 1,809,059 General and administrative expenses — — 5,542,483 Income from discontinued operations before disposal of discontinued operations and income taxes — — 2,341,825 Loss on disposal of discontinued operations — — (38,377,623) Income taxes — — 626,583 Loss from discontinued operations $ — $ — $ (36,662,381) The following table presents operating, investing and financing cash flows for the Company’s discontinued operations: Year ended March 31, 2021 2020 2019 Cash provided by operating activities: $ — $ — $ 3,553,854 Cash provided by (used in) investing activities: — — 1,138,084 Cash provided by (used in) financing activities: $ — $ — $ (17,126,000) |
Discontinued Operations
Discontinued Operations | 12 Months Ended |
Mar. 31, 2021 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Discontinued Operations | Assets Held for Sale In the fourth quarter of fiscal 2020 the Company moved its corporate headquarters from properties it owned outright in Greenville, South Carolina to leased office space in downtown Greenville, South Carolina. Under ASC 360-10, the properties met the criteria for classification as held for sale as of March 31, 2020. During the second quarter of fiscal 2021 the Company completed the sale of two of the three buildings held for sale, resulting in an aggregate loss of $37,579. The loss on sale of assets held for sale is included as a component of insurance income, net and other income in the Company's Consolidated Statement of Operations. The Company expects to complete the sale of the third, and final, building held for sale within the next twelve months. The following table reconciles the major classes of assets held for sale to the amounts presented in the Consolidated Balance Sheets: March 31, 2020 March 31, 2020 Assets held for sale: Property and equipment, net $ 1,143,528 $ 3,991,498 Total assets held for sale $ 1,143,528 $ 3,991,498 On August 3, 2018 the Company and its affiliates completed the sale of the Company's Mexico operating segment in its entirety. The Company sold all of the issued and outstanding capital stock and equity interest of WAC de Mexico and SWAC to the Purchasers, effective as of July 1, 2018, for a purchase price of approximately $44.4 million. Under the terms of the stock purchase agreement, we are obligated to indemnify the Purchasers for claims and liabilities relating to certain investigations of WAC de Mexico, SWAC, or the Sellers by the DOJ or the SEC that commenced prior to July 1, 2018. Additionally, the Company has provided limited ParaData systems and software training to the Purchasers, as requested. The Company has not and will not have any other involvement with the Mexico operating segment subsequent to the sale's effective date. The following table reconciles the major classes of line items constituting pre-tax income of discontinued operations to the amounts presented in the Consolidated Statements of Operations: Year ended March 31, 2021 2020 2019 Revenues $ — $ — $ 9,693,367 Provision for loan losses — — 1,809,059 General and administrative expenses — — 5,542,483 Income from discontinued operations before disposal of discontinued operations and income taxes — — 2,341,825 Loss on disposal of discontinued operations — — (38,377,623) Income taxes — — 626,583 Loss from discontinued operations $ — $ — $ (36,662,381) The following table presents operating, investing and financing cash flows for the Company’s discontinued operations: Year ended March 31, 2021 2020 2019 Cash provided by operating activities: $ — $ — $ 3,553,854 Cash provided by (used in) investing activities: — — 1,138,084 Cash provided by (used in) financing activities: $ — $ — $ (17,126,000) |
Subsequent Events
Subsequent Events | 12 Months Ended |
Mar. 31, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Events | Subsequent EventsManagement is not aware of any significant events occurring subsequent to the balance sheet date that would have a material effect on the financial statements thereby requiring adjustment or disclosure. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Basis of Accounting, Policy | Nature of Operations The Company is a small-dollar consumer finance (installment loan) company headquartered in Greenville, South Carolina that offers short-term small loans, medium-term larger loans, related credit insurance products and ancillary products and services to individuals who have limited access to other sources of consumer credit. It also offers income tax return preparation services to its customer base and to others. As of March 31, 2021, the Company operated 1,205 branches in Alabama, Georgia, Idaho, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Missouri, New Mexico, Oklahoma, South Carolina, Tennessee, Texas, Utah, and Wisconsin. Branches in the aforementioned states operate under one of the following names: Amicable Finance, Colonial Finance, Freeman Finance, General Credit, Midwestern Loans, World Acceptance, or World Finance. On August 3, 2018 the Company and its affiliates completed the sale of the Company's Mexico operating segment in its entirety, effective as of July 1, 2018. Thus, the Company operated no branches in Mexico as of March 31, 2021 or 2020. During the first quarter of fiscal 2019, branches in Mexico operated under the name Préstamos Avance or Pr é stamos Viva. The Company is subject to numerous lending regulations that vary by jurisdiction. |
Principles of Consolidation | Principles of Consolidation The Consolidated Financial Statements include the accounts of World Acceptance Corporation and its wholly-owned subsidiaries (the “Company”). Subsidiaries consist of operating entities in various states, ParaData Financial Systems (a software company acquired during fiscal 1994), and WAC Insurance Company, Ltd. (a captive reinsurance company established in fiscal 1994). All significant inter-company balances and transactions have been eliminated in consolidation. The financial statements of the Company’s former foreign subsidiaries in Mexico were prepared using the local currency as the functional currency. Assets and liabilities of these subsidiaries were translated into U.S. dollars at the then-current exchange rate while income and expense are translated at an average exchange rate for the applicable period. The resulting translation gains and losses were recognized as a component of equity in “Accumulated Other Comprehensive Loss, net.” |
Use of Estimates in the Preparation of Financial Statements | Use of Estimates in the Preparation of Consolidated Financial Statements The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The most significant item subject to such estimates and assumptions that could materially change in the near term is the allowance for credit losses. |
Reclassification, Policy | Reclassification Certain prior period amounts have been reclassified to conform to the current presentation. Such reclassifications had no impact on previously reported net income or shareholders' equity. |
Business Segments | Business Segments The Company reports operating segments in accordance with FASB ASC Topic 280. Operating segments are components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and assess performance. FASB ASC Topic 280 requires that a public enterprise report a measure of segment profit or loss, certain specific revenue and expense items, segment assets, information about the way that the operating segments were determined and other items. The Company has one reportable segment. The other revenue generating activities of the Company, including the sale of insurance products, income tax preparation, and the automobile club, are done within the existing branch |
Cash and Cash Equivalents | Cash and Cash Equivalents For purposes of the statement of cash flows, the Company considers all highly liquid investments with a maturity of three months or less from the date of original issuance to be cash equivalents. As of March 31, 2021 and 2020 the Company had $7.0 million and $5.4 million, respectively, in restricted cash associated with its captive insurance subsidiary that reinsures a portion of the credit insurance sold in connection with loans made by the Company. |
Loans and Interest Income | Loans and Interest and Fee Income The Company is licensed to originate consumer loans in the states of Alabama, Georgia, Idaho, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Missouri, New Mexico, Oklahoma, South Carolina, Texas, Tennessee, Utah, and Wisconsin. During fiscal 2021, 2020, and 2019 the Company originated loans generally ranging up to $3,500, with terms of 48 months or fewer. Experience indicates that a majority of the consumer loans are refinanced, and the Company accounts for the majority of the refinancings as new loans. Generally a customer must make multiple payments in order to qualify for refinancing. Furthermore, the Company's lending policy has predetermined lending amounts so that in most cases a refinancing will result in advancing additional funds. The Company believes that the advancement of additional funds constitutes more than a minor modification to the terms of the existing loan if the present value of the cash flows under the terms of the new loan will be 10% or more of the present value of the remaining cash flows under the terms of the original loan. The following table sets forth information about our loan products for fiscal 2021: Minimum Origination Maximum Origination Minimum Term Maximum Term Small loans $ 250 $ 2,450 4 30 Large loans 2,500 21,400 12 48 Tax advance loans 100 5,000 8 8 Gross loans receivable at March 31, 2021 and 2020 consisted of the following: 2021 2020 Small loans $ 620,959,979 $ 761,364,753 Large loans 475,470,271 442,683,915 Tax advance loans 8,316,011 5,822,698 Total gross loans $ 1,104,746,261 $ 1,209,871,366 Fees received and direct costs incurred for the origination of loans are deferred and amortized to interest income over the contractual lives of the loans using the interest method. Unamortized amounts are recognized in income at the time that loans are refinanced or paid in full except for those refinancings that do not constitute a more than minor modification. Loans are carried at the gross amount outstanding, reduced by unearned interest and insurance income, net of deferred origination fees and direct costs and an allowance for credit losses. The Company recognizes interest and fee income using the interest method. Charges for late payments are credited to income when collected. With the exception of tax advance loans, which are interest free, the Company offers its loans at the prevailing statutory rates for terms not to exceed 48 months. Management believes that the carrying value approximates the fair value of its loan portfolio. |
Nonaccrual Policy | Nonaccrual PolicyThe accrual of interest is discontinued when a loan is 61 days or more past the contractual due date. When the interest accrual is discontinued, all unpaid accrued interest is reversed against interest income. While a loan is on nonaccrual status, interest revenue is recognized only when a payment is received. Once a loan moves to nonaccrual status, it remains in nonaccrual status until it is paid out, charged off or refinanced. |
Allowance for Loan Losses | Allowance for Credit Losses Refer to Note 2, “Allowance for Credit Losses and Credit Quality Indicators,” in this Annual Report on Form 10-K for information regarding the Company's adoption of the CECL allowance model on April 1, 2020 and a description of the methodology it utilizes. |
Impaired Loans | Impaired LoansThe Company defines impaired loans as bankrupt accounts and accounts 91 days or more past due on a recency basis. In accordance with the Company’s charge-off policy, once a loan is deemed uncollectible, 100% of the net investment is charged off, except in the case of a borrower who has filed for bankruptcy. As of March 31, 2021, bankrupt accounts that had not been charged off were approximately $3.2 million. Bankrupt accounts 91 days or more past due on a recency basis are reserved at 100% of the gross loan balance. The Company also considers any accounts 91 days or more past due on a recency basis to be impaired, and such accounts are reserved at 100% of the gross loan balance. |
Property and Equipment | Property and Equipment Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is recorded using the straight-line method over the estimated useful life of the related asset as follows: buildings, 25 to 40 years; furniture and fixtures, 5 to 10 years; equipment, 3 to 7 years; and vehicles, 3 years. Amortization of leasehold improvements is recorded using the straight-line method over the lesser of the estimated useful life of the asset or the term of the lease. Additions to premises and equipment and major replacements or improvements are added at cost. Maintenance, repairs, and minor replacements are charged to operating expense as incurred. When assets are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the consolidated statement of operations. |
Operating Leases | Operating Leases The Company’s branch leases typically have a lease term of three |
Other Assets | Other Assets Other assets include cash surrender value of life insurance policies, prepaid expenses, debt issuance costs, and other deposits. |
Intangible Assets and Goodwill | Intangible Assets and Goodwill Intangible assets include the cost of acquiring existing customers ("customer lists"), and the fair value assigned to non-compete agreements. Customer lists are amortized on a straight line or accelerated basis over their estimated period of benefit, ranging from 8 to 23 years with a weighted average of approximately 9.5 years. Non-compete agreements are amortized on a straight line basis over the term of the agreement, ranging from 3 to 5.3 years with a weighted average of approximately 5.0 years. Customer lists are allocated at a branch level and are evaluated for impairment at a branch level when a triggering event occurs, in accordance with FASB ASC Topic 360-10-05. If a triggering event occurs, the impairment loss to the customer list is generally the remaining unamortized customer list balance. In most acquisitions, the original fair value of the customer list allocated to a branch is less than $100,000, and management believes that in the event a triggering event were to occur, the impairment loss to an unamortized customer list would be immaterial. |
Impairment of Long-Lived Assets | Impairment of Long-Lived Assets The Company assesses impairment of long-lived assets, including property and equipment and intangible assets, whenever changes or events indicate that the carrying amount may not be recoverable. The Company assesses impairment of these assets generally at the branch level based on the operating cash flows of the branch and the Company’s plans for branch closings. The Company will write down such assets to fair value if, based on an analysis, the sum of the expected future undiscounted cash flows is less than the carrying amount of the assets. The Company did not record any impairment charges for the fiscal year ended 2021, 2020, or 2019. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments FASB ASC Topic 825 requires disclosures about the fair value of all financial instruments, regardless of whether the financial instrument is recognized on the balance sheet, for which it is practicable to estimate that value. In cases where quoted market prices are not available, fair values are based on estimates using present value or other valuation techniques. The Company’s financial instruments for the periods reported consist of the following: cash and cash equivalents, loans receivable and senior notes payable. Fair value approximates carrying value for all of these instruments. |
Insurance Premiums | Insurance Premiums and CommissionsInsurance premiums for credit life, accident and health, property and unemployment insurance written in connection with certain loans, net of refunds and applicable advance insurance commissions retained by the Company, are remitted monthly to an insurance company. All commissions are credited to unearned insurance commissions and recognized as income over the life of the related insurance contracts. The Company recognizes insurance income using the Rule of 78s method for credit life (decreasing term), credit accident and health, unemployment insurance and the Pro Rata method for credit life (level term) and credit property. |
Non-filing Insurance | Non-filing Insurance Non-filing insurance premiums are charged on certain loans in lieu of recording and perfecting the Company's security interest in the assets pledged. The premiums and recoveries are remitted to a third party insurance company and are not reflected in the accompanying Consolidated Financial Statements (see Note 8). Claims paid by the third party insurance company result in a reduction to loan losses. Certain losses related to such loans, which are not recoverable through life, accident and health, property, or unemployment insurance claims are reimbursed through non-filing insurance claims subject to policy limitations. Any remaining losses are charged to the allowance for credit losses. |
Income Taxes | Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment related to additional facts and circumstances occurs. |
Earnings Per Share | Earnings Per Share Earnings per share (“EPS”) is computed in accordance with FASB ASC Topic 260. Basic EPS includes no dilution and is computed by dividing net income by the weighted-average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution of securities that could share in the earnings of the Company. Potential common stock included in the diluted EPS computation consists of stock options and restricted stock, which are computed using the treasury stock method. See Note 11 for the reconciliation of the numerators and denominators for basic and dilutive EPS calculations. |
Stock-Based Compensation | Stock-Based Compensation FASB ASC Topic 718-10 requires companies to recognize in the income statement the grant-date fair value of stock options and other equity-based compensation issued to employees. FASB ASC Topic 718-10 does not change the accounting guidance for share-based payment transactions with parties other than employees provided in FASB ASC Topic 718-10. Under FASB ASC Topic 718-10, the way an award is classified will affect the measurement of compensation cost. Liability-classified awards are remeasured to fair value at each balance-sheet date until the award is settled. Equity-classified awards are measured at grant-date fair value, amortized over the subsequent vesting period, and are not subsequently remeasured. The fair value of non-vested stock awards for the purposes of recognizing stock-based compensation expense is the market price of the stock on the grant date. The fair value of options is estimated on the grant date using the Black-Scholes option pricing model (see Note 12). At March 31, 2021, the Company had several share-based employee compensation plans, which are described more fully in Note 12. |
Share Repurchases | Share Repurchases On March 12, 2020, the Board of Directors authorized the Company to repurchase up to $30.0 million of the Company’s outstanding common stock, inclusive of the amount that remains available for repurchase under prior repurchase authorizations. As of March 31, 2021, the Company had $21.4 million in aggregate remaining repurchase capacity. The timing and actual number of shares of common stock repurchased will depend on a variety of factors, including the stock price, corporate and regulatory requirements, restrictions under the revolving credit facility and other market and economic conditions. The Company continues to believe stock repurchases are a viable component of the Company’s long-term financial strategy and an excellent use of excess cash when the opportunity arises. However, our revolving credit agreement limits share repurchases to 50% of consolidated adjusted net income in any fiscal year commencing with the fiscal year ending March 31, 2017 without prior written consent of the lenders. As of March 31, 2021 our debt outstanding was $405.0 million and our shareholders' equity was $404.9 million resulting in a debt-to-equity ratio of 1.0:1.0. |
Comprehensive Income | Comprehensive Income Total comprehensive income consists of net income and other comprehensive income (loss). The Company’s other comprehensive income (loss) and accumulated other comprehensive income (loss) are composed of foreign currency translation adjustments. |
Concentration of Risk | Concentration of RiskThe Company generally serves individuals with limited access to other sources of consumer credit such as banks, credit unions, other consumer finance businesses and credit card lenders. During the year ended March 31, 2021, the Company operated in sixteen states in the United States. For the years ended March 31, 2021, 2020, and 2019, total revenue within the Company's four largest states (Texas, Georgia, Tennessee, and South Carolina) accounted for approximately 53%, 56% and 57%, respectively, of the Company's total revenues. The Company maintains amounts in bank accounts which, at times, may exceed federally insured limits. The Company has not experienced losses in such accounts, which are maintained with large domestic banks. Management believes the Company’s exposure to credit risk is minimal for these accounts. |
Advertising Costs | Advertising CostsAdvertising costs are expensed when incurred. |
Recently Adopted Accounting Standards | Recently Adopted Accounting Standards Measurement of Credit Losses on Financial Instruments ASU 2016-13 (and all subsequent ASUs on this topic) introduce the CECL model, a new credit loss methodology, replacing multiple existing impairment methods in current GAAP, which generally require that a loss be incurred before it is recognized. The amendments in this ASU require loss estimates be determined over the lifetime of the asset and broaden the information that an entity must consider in developing its expected credit losses. The ASU does not specify a method for measuring expected credit losses and allows an entity to apply methods that reasonably reflect its expectations of the credit loss estimate based on the entity’s size, complexity, and risk profile. In addition, the disclosures of credit quality indicators in relation to the amortized cost of financing receivables, a current disclosure requirement, are further disaggregated by year of origination. The Company adopted this ASU (and all subsequent ASUs on this topic) as of April 1, 2020 using the modified retrospective approach. The adoption of this pronouncement resulted in the recognition of a $28.6 million increase in the allowance for credit losses on our opening balance sheet as of April 1, 2020, with a corresponding net-of-tax $21.2 million reduction in retained earnings and a $7.4 million increase to deferred income taxes, net. Recently Issued Accounting Standards Not Yet Adopted We reviewed all newly issued accounting pronouncements and concluded that they are either not applicable to our business or are not expected to have a material effect on the consolidated financial statements as a result of future adoption. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Mar. 31, 2021 | |
Accounting Policies [Abstract] | |
Summary of gross loan | The following table sets forth information about our loan products for fiscal 2021: Minimum Origination Maximum Origination Minimum Term Maximum Term Small loans $ 250 $ 2,450 4 30 Large loans 2,500 21,400 12 48 Tax advance loans 100 5,000 8 8 Gross loans receivable at March 31, 2021 and 2020 consisted of the following: 2021 2020 Small loans $ 620,959,979 $ 761,364,753 Large loans 475,470,271 442,683,915 Tax advance loans 8,316,011 5,822,698 Total gross loans $ 1,104,746,261 $ 1,209,871,366 The following is a summary of gross loans receivable by Customer Tenure as of: Customer Tenure March 31, 2021 0 to 5 months $ 92,378,097 6 to 17 months 106,742,121 18 to 35 months 169,361,910 36 to 59 months 130,655,627 60+ months 597,292,495 Tax advance loans 8,316,011 Total gross loans $ 1,104,746,261 |
Allowance for Credit Losses a_2
Allowance for Credit Losses and Credit Quality Information (Tables) | 12 Months Ended |
Mar. 31, 2021 | |
Receivables [Abstract] | |
Summary of gross loan | The following table sets forth information about our loan products for fiscal 2021: Minimum Origination Maximum Origination Minimum Term Maximum Term Small loans $ 250 $ 2,450 4 30 Large loans 2,500 21,400 12 48 Tax advance loans 100 5,000 8 8 Gross loans receivable at March 31, 2021 and 2020 consisted of the following: 2021 2020 Small loans $ 620,959,979 $ 761,364,753 Large loans 475,470,271 442,683,915 Tax advance loans 8,316,011 5,822,698 Total gross loans $ 1,104,746,261 $ 1,209,871,366 The following is a summary of gross loans receivable by Customer Tenure as of: Customer Tenure March 31, 2021 0 to 5 months $ 92,378,097 6 to 17 months 106,742,121 18 to 35 months 169,361,910 36 to 59 months 130,655,627 60+ months 597,292,495 Tax advance loans 8,316,011 Total gross loans $ 1,104,746,261 |
Assessment of the credit quality | The following tables provide a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at March 31, 2021: Term Loans By Origination Loans Up to Between Between Between Between More than Total Current $ 970,526,682 $ 45,769,052 $ 2,102,732 $ 154,890 $ 14,444 $ 831 $ 1,018,568,631 30 - 60 days past due 21,862,634 2,011,261 153,417 21,426 3,500 2,069 24,054,307 61 - 90 days past due 18,039,010 1,208,936 88,119 11,800 571 — 19,348,436 91 or more days past due 31,126,328 3,120,210 183,434 14,028 14,708 168 34,458,876 Total $ 1,041,554,654 $ 52,109,459 $ 2,527,702 $ 202,144 $ 33,223 $ 3,068 $ 1,096,430,250 Term Loans By Origination Tax advance loans Up to Between Between Between Between More than Current $ 7,583,075 $ 9,360 $ — $ — $ — $ — $ 7,592,435 30 - 60 days past due 686,667 1,423 — — — — 688,090 61 - 90 days past due — — 321 — — — 321 91 or more days past due — 34,509 656 — — — 35,165 Total $ 8,269,742 $ 45,292 $ 977 $ — $ — $ — $ 8,316,011 Total gross loans $ 1,104,746,261 The following tables provide a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at March 31, 2021: Term Loans By Origination Loans Up to Between Between Between Between More than Total Current $ 948,353,853 $ 39,661,944 $ 1,522,148 $ 83,073 $ 1,790 $ 831 $ 989,623,639 30 - 60 days past due 29,300,148 1,872,816 72,187 1,322 — — 31,246,473 61 - 90 days past due 23,075,264 1,363,196 75,343 567 — — 24,514,370 91 or more days past due 40,825,388 9,211,503 858,024 117,183 31,433 2,237 51,045,768 Total $ 1,041,554,653 $ 52,109,459 $ 2,527,702 $ 202,145 $ 33,223 $ 3,068 $ 1,096,430,250 Term Loans By Origination Tax advance loans Up to Between Between Between Between More than Total Current $ 7,583,075 $ — $ — $ — $ — $ — $ 7,583,075 30 - 60 days past due 686,667 — — — — — 686,667 61 - 90 days past due — — — — — — — 91 or more days past due — 45,292 977 — — — 46,269 Total $ 8,269,742 $ 45,292 $ 977 $ — $ — $ — $ 8,316,011 Total gross loans $ 1,104,746,261 The following is an assessment of the credit quality for March 31, 2020: Credit risk Consumer loans- non-bankrupt accounts $ 1,203,552,152 Consumer loans- bankrupt accounts 6,319,214 Total gross loans 1,209,871,366 Consumer credit exposure Credit risk profile based on payment activity, performing 1,104,130,714 Contractual non-performing, 61 days or more delinquent (1) 105,740,652 Total gross loans 1,209,871,366 Credit risk profile based on customer type New borrower 124,800,193 Former borrower 127,108,125 Refinance 935,448,882 Delinquent refinance 22,514,166 Total gross loans $ 1,209,871,366 _______________________________________________________ (1) Loans in non-accrual status |
Summary of changes in the allowance for loan losses | The following is a summary of the changes in the allowance for credit losses for the years ended March 31, 2021, 2020, and 2019: 2021 2020 2019 Balance at beginning of period $ 96,487,856 81,519,624 66,088,139 Impact of ASC 326 adoption 28,628,368 — — Provision for loan losses 86,244,714 181,730,182 148,426,578 Loan losses (141,270,125) (183,439,199) (148,308,199) Recoveries 21,631,475 16,677,249 15,313,106 Balance at end of period $ 91,722,288 96,487,856 81,519,624 |
Summary of loans individually and collectively evaluated for impairment | March 31, 2020 Loans individually Loans collectively Total Gross loans in bankruptcy, excluding contractually delinquent $ 5,165,752 — 5,165,752 Gross loans contractually delinquent 70,719,727 — 70,719,727 Loans not contractually delinquent and not in bankruptcy — 1,133,985,887 1,133,985,887 Gross loan balance 75,885,479 1,133,985,887 1,209,871,366 Unearned interest and fees (16,848,762) (292,131,962) (308,980,724) Net loans 59,036,717 841,853,925 900,890,642 Allowance for loan losses (54,090,509) (42,397,347) (96,487,856) Loans, net of allowance for loan losses $ 4,946,208 799,456,578 804,402,786 |
Summary of the past due receivables | The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at March 31, 2021: Days Past Due - Recency Basis Customer Tenure Current 30 - 60 61 - 90 Over 90 Total Past Due Total Loans 0 to 5 months $ 72,702,970 $ 4,799,102 $ 5,680,380 $ 9,195,642 $ 19,675,124 $ 92,378,094 6 to 17 months 94,466,209 3,187,347 2,798,411 6,290,155 12,275,913 106,742,122 18 to 35 months 158,217,605 3,570,696 2,592,402 4,981,208 11,144,306 169,361,911 36 to 59 months 123,542,346 2,432,489 1,753,291 2,927,501 7,113,281 130,655,627 60+ months 569,639,500 10,064,674 6,523,952 11,064,370 27,652,996 597,292,496 Tax advance loans 7,592,435 688,090 321 35,165 723,576 8,316,011 Total gross loans 1,026,161,065 24,742,398 19,348,757 34,494,041 78,585,196 1,104,746,261 Unearned interest, insurance and fees (259,492,219) (6,256,776) (4,892,850) (8,722,739) (19,872,365) (279,364,584) Total net loans $ 766,668,846 $ 18,485,622 $ 14,455,907 $ 25,771,302 $ 58,712,831 $ 825,381,677 Percentage of period-end gross loans receivable 2.2% 1.8% 3.1% 7.1% The following tables provide a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at March 31, 2021: Days Past Due - Contractual Basis Loans Current 30 - 60 61 - 90 Over 90 Total Past Due Total Loans 0 to 5 months $ 70,532,439 $ 5,245,878 $ 6,019,264 $ 10,580,514 $ 21,845,656 $ 92,378,095 6 to 17 months 90,679,304 3,936,937 3,267,446 8,858,434 16,062,817 106,742,121 18 to 35 months 153,922,334 4,471,202 3,488,629 7,479,745 15,439,576 169,361,910 36 to 59 months 120,168,698 3,229,253 2,337,625 4,920,052 10,486,930 130,655,628 60+ months 554,320,865 14,363,203 9,401,406 19,207,022 42,971,631 597,292,496 Tax advance loans 7,583,075 686,667 — 46,269 732,936 8,316,011 Total gross loans $ 997,206,715 $ 31,933,140 $ 24,514,370 $ 51,092,036 $ 107,539,546 $ 1,104,746,261 Unearned interest, insurance and fees $ (252,170,339) $ (8,075,147) $ (6,199,113) $ (12,919,985) $ (27,194,245) $ (279,364,584) Total net loans $ 745,036,376 $ 23,857,993 $ 18,315,257 $ 38,172,051 $ 80,345,301 $ 825,381,677 Percentage of period-end gross loans receivable 2.9% 2.2% 4.6% 9.7% The following is a summary of the past due receivables as of: March 31, Contractual basis: 30-60 days past due $ 49,137,102 61-90 days past due 35,020,925 91 days or more past due 70,719,727 Total $ 154,877,754 Percentage of period-end gross loans receivable 12.8 % Recency basis: 30-60 days past due $ 48,206,910 61-90 days past due 28,450,942 91 days or more past due 50,669,837 Total $ 127,327,689 Percentage of period-end gross loans receivable 10.5 % |
Financing Receivable, Nonaccrual | It also shows year-to-date interest income recognized on nonaccrual loans: Nonaccrual Financial Assets Customer Tenure As of March 31, 2021 As of March 31, 2020 Financial Assets 61 Days or More Past Due, Not on Nonaccrual Status Nonaccrual Financial Assets With No Allowance as of March 31, 2021 Interest Income 0 to 5 months $ 17,191,922 $ 26,040,593 $ — $ — $ 1,705,371 6 to 17 months 13,211,641 17,466,450 — — 2,433,144 18 to 35 months 12,088,377 13,723,295 — — 2,195,160 36 to 59 months 8,161,951 10,071,288 — — 1,609,059 60+ months 31,925,232 44,293,545 — — 6,747,722 Tax advance loans 46,269 41,573 — — — Unearned interest, insurance and fees (20,894,036) (28,510,140) Total $ 61,731,356 $ 83,126,604 $ — $ — $ 14,690,456 |
Property and Equipment (Tables)
Property and Equipment (Tables) | 12 Months Ended |
Mar. 31, 2021 | |
Property, Plant and Equipment [Abstract] | |
Property and Equipment | Property and equipment consist of: March 31, 2021 March 31, 2020 Land $ 100,443 100,443 Building and leasehold improvements 17,882,214 17,048,098 Furniture and equipment 54,735,353 51,376,746 72,718,010 68,525,287 Less accumulated depreciation and amortization (46,377,973) (43,764,179) Total $ 26,340,037 24,761,108 |
Intangible Assets (Tables)
Intangible Assets (Tables) | 12 Months Ended |
Mar. 31, 2021 | |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | |
Gross carrying amount and related accumulated amortization of definite-lived intangible assets | The following table provides the gross carrying amount and related accumulated amortization of definite-lived intangible assets: March 31, 2021 March 31, 2020 Gross Carrying Accumulated Net Intangible Asset Gross Carrying Accumulated Net Intangible Asset Cost of customer lists $ 54,777,749 (32,322,607) 22,455,142 $ 50,411,969 (27,215,464) 23,196,505 Value assigned to non-compete agreements 10,252,143 (9,169,768) 1,082,375 10,054,643 (8,802,671) 1,251,972 Total $ 65,029,892 (41,492,375) 23,537,517 $ 60,466,612 (36,018,135) 24,448,477 |
Goodwill (Tables)
Goodwill (Tables) | 12 Months Ended |
Mar. 31, 2021 | |
Goodwill [Abstract] | |
Changes in the carrying amount of goodwill | The following summarizes the changes in the carrying amount of goodwill for the years ended March 31, 2021 and 2020: 2021 2020 Balance at beginning of year: Goodwill $ 7,450,422 7,114,094 Accumulated goodwill impairment losses (79,631) (79,631) Goodwill, net $ 7,370,791 7,034,463 Goodwill acquired during the year $ — 336,328 Impairment losses — — Balance at end of year: Goodwill $ 7,450,422 7,450,422 Accumulated goodwill impairment losses (79,631) (79,631) Goodwill, net $ 7,370,791 7,370,791 |
Notes Payable (Tables)
Notes Payable (Tables) | 12 Months Ended |
Mar. 31, 2021 | |
Debt Disclosure [Abstract] | |
Aggregate annual maturities of the notes payable | As of March 31, 2021, the aggregate annual maturities of the notes payable for each of the five fiscal years subsequent to March 31, 2021 were as follows: 2022 $ — 2023 — 2024 — 2025 405,007,500 2026 — Total future debt payments $ 405,007,500 |
Insurance and Other Income (Tab
Insurance and Other Income (Tables) | 12 Months Ended |
Mar. 31, 2021 | |
Insurance Commissions and other income [Abstract] | |
Insurance Commissions and Other Income | Insurance and other income for the years ending March 31, 2021, 2020, and 2019 consist of: 2021 2020 2019 Insurance revenue $ 44,214,454 50,360,730 45,182,596 Tax return preparation revenue 18,098,087 20,936,447 21,454,117 Auto club membership revenue 7,863,145 6,254,748 4,452,018 Other 4,244,079 4,150,319 4,299,917 Insurance and other income $ 74,419,765 81,702,244 75,388,648 |
Non-filing Insurance (Tables)
Non-filing Insurance (Tables) | 12 Months Ended |
Mar. 31, 2021 | |
Non-file Insurance [Abstract] | |
Non-filing Insurance | The Company maintains non-filing insurance coverage with an unaffiliated insurance company. The following is a summary of the non-filing insurance activity for the years ended March 31, 2021, 2020, and 2019: 2021 2020 2019 Insurance premiums written $ 7,072,647 8,251,927 6,164,871 Recoveries on claims paid $ 959,620 1,001,288 996,482 Claims paid $ 5,223,484 7,570,126 6,553,271 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Mar. 31, 2021 | |
Leases [Abstract] | |
Lease, Cost | The following table reports information about the Company's lease cost for the years ended March 31, 2021 and 2020: 2021 2020 Lease Cost Operating lease cost $ 27,977,226 $ 26,244,323 Short-term lease cost 1,800 4,500 Variable lease cost 3,621,748 3,376,275 Total lease cost $ 31,600,774 $ 29,625,098 The following table reports other information about the Company's leases for years ended March 31, 2021 and 2020: 2021 2020 Other Lease Information Cash paid for amounts included in the measurement of lease liabilities $ 27,559,260 $ 25,618,886 Right-of-use assets obtained in exchange for new operating lease liabilities $ 12,482,167 $ 36,826,045 Weighted average remaining lease term — operating leases 7.3 years 8.4 years Weighted-average discount rate — operating leases 6.3 % 6.7 % |
Lessee, Operating Lease, Liability, Maturity | The following table reports information about the maturity of the Company's operating leases as of March 31, 2021: Operating lease liability maturity analysis FY2022 25,697,140 FY2023 21,366,591 FY2024 17,262,768 FY2025 12,608,028 FY2026 8,874,883 Thereafter 31,311,884 Total undiscounted lease liability $ 117,121,294 Imputed interest 25,403,219 Total discounted lease liability $ 91,718,075 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Mar. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Income tax expense (benefit) | Income tax expense (benefit) from continuing operations consists of: Current Deferred Total Year ended March 31, 2021 Continuing Operations- Federal $ 16,443,592 4,077,609 20,521,201 Continuing Operations- State and local 1,025,645 1,573,753 2,599,398 $ 17,469,237 5,651,362 23,120,599 Year ended March 31, 2020 Continuing Operations- Federal $ 3,307,872 (224,604) 3,083,268 Continuing Operations- State and local 2,871,179 797,518 3,668,697 $ 6,179,051 572,914 6,751,965 Year ended March 31, 2019 Continuing Operations- Federal $ 20,508,247 (1,833,943) 18,674,304 Continuing Operations- State and local (871,439) (1,821,808) (2,693,247) $ 19,636,808 (3,655,751) 15,981,057 |
Income tax expense reconciliation to U.S federal income tax rate to pretax income | The differences between income taxes expected at the U.S. federal statutory income tax rate of 21% and the reported income tax expense from continuing operations for March 31, 2021, 2020 and 2019 are summarized as follows: 2021 2020 2019 Expected income tax $ 23,394,720 7,330,983 18,874,500 Increase (reduction) in income taxes resulting from: State tax (excluding state tax credits), net of federal benefit 2,053,524 3,398,271 1,576,915 Federal tax credits (net) (1,173,435) (7,616,236) — State tax credits — (500,000) (3,704,580) Revalue deferred tax assets and liabilities — — (852,523) Uncertain tax positions (2,107,263) (167,455) (183,929) Nondeductible penalties 8,274 4,562,830 2,210 Executive compensation limitation under Section 162(m) 1,203,203 1,305,975 37,457 Excess tax benefits related to equity compensation (996,769) (612,987) (287,703) Prior year adjustments (30,953) (672,358) 106,075 Other, net 769,298 (277,058) 412,635 $ 23,120,599 6,751,965 15,981,057 The differences between income taxes expected at the U.S. federal statutory income tax rate of 21% and the reported income tax expense from discontinued operations for March 31, 2021, 2020 and 2019 are summarized as follows: 2021 2020 2019 Expected income tax $ — — 491,783 Increase (reduction) in income taxes resulting from: Foreign income adjustments — — 187,974 Other, net — — (53,174) $ — — 626,583 |
Tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities | The tax effects of temporary differences from continuing operations that give rise to significant portions of the deferred tax assets and deferred tax liabilities at March 31, 2021 and 2020 are presented below: 2021 2020 Deferred tax assets: Allowance for credit losses $ 22,908,670 23,900,236 Unearned insurance commissions 10,080,766 9,964,655 Accrued expenses primarily related to employee benefits 13,676,701 12,730,245 Reserve for uncollectible interest 645,113 1,205,082 Lease liability 22,231,591 25,309,841 Foreign tax credit carryforward 3,254,926 3,254,926 Capital loss carryforward 7,928,184 7,784,059 State net operating loss carryforwards 78,358 387,558 Gross deferred tax assets 80,804,309 84,536,602 Less valuation allowance (11,184,384) (11,040,259) Net deferred tax assets 69,619,925 73,496,343 Deferred tax liabilities: Fair value adjustment for loans receivable (12,362,590) (14,065,135) Property and equipment (5,902,421) (5,097,147) Intangible assets (243,574) (925,319) Deferred net loan origination costs (1,268,653) (1,664,486) Prepaid expenses (1,412,337) (1,185,759) Right-of-use asset (21,826,178) (25,045,690) Other (1,611,430) (2,254,822) Gross deferred tax liabilities (44,627,183) (50,238,358) Deferred income taxes, net $ 24,992,742 23,257,985 |
Reconciliation of the beginning and ending amount of unrecognized tax benefits | A reconciliation of the beginning and ending amount of unrecognized tax benefits at March 31, 2021, 2020, and 2019 are presented below: 2021 2020 2019 Unrecognized tax benefit balance beginning of year $ 4,351,811 4,043,623 6,946,229 Gross increases for tax positions of current year 36,541 246,725 54,025 Gross increases (decreases) for tax positions of prior years — 786,674 (138,405) Settlements with tax authorities (1,968,702) — (1,356,714) Lapse of statute of limitations (608,406) (725,211) (1,461,512) Unrecognized tax benefit balance end of year $ 1,811,244 4,351,811 4,043,623 |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 12 Months Ended |
Mar. 31, 2021 | |
Earnings Per Share [Abstract] | |
Summary of basic and diluted average common shares outstanding | The following is a reconciliation of the numerators and denominators of the basic and diluted EPS from continuing operations calculations: For the year ended March 31, 2021 Income Shares Per Share Basic EPS Income from continuing operations available to common shareholders $ 88,282,828 6,493,898 $ 13.59 Effect of dilutive securities options and restricted stock — 178,212 Diluted EPS Income from continuing operations available to common shareholders including dilutive securities $ 88,282,828 6,672,110 $ 13.23 For the year ended March 31, 2020 Income Shares Per Share Amount Basic EPS Income from continuing operations available to common shareholders $ 28,157,478 7,688,242 $ 3.66 Effect of dilutive securities options and restricted stock — 264,658 Diluted EPS Income from continuing operations available to common shareholders including dilutive securities $ 28,157,478 7,952,900 $ 3.54 For the year ended March 31, 2019 Income Shares Per Share Amount Basic EPS Income from continuing operations available to common shareholders $ 73,897,515 8,994,036 $ 8.22 Effect of dilutive securities options and restricted stock — 210,341 Diluted EPS Income from continuing operations available to common shareholders including dilutive securities $ 73,897,515 9,204,377 $ 8.03 |
Benefit Plans (Tables)
Benefit Plans (Tables) | 12 Months Ended |
Mar. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Schedule of performance shares, activity | The Performance Share performance targets are set forth below. Trailing 4-Quarter EPS Targets for Restricted Stock Eligible for Vesting $16.35 40% $20.45 60% Trailing 4-Quarter EPS Targets for Options Eligible for Vesting $25.30 100% |
Schedule of weighted-average assumptions | This fair value was estimated at grant date using the weighted-average assumptions listed below. 2021 2020 2019 Dividend yield 0 % 0 % 0 % Expected volatility 57.53 % 52.28 % 48.94 % Average risk-free interest rate 0.59 % 1.58 % 3.01 % Expected life 6.3 years 6.3 years 6.7 years |
Summary schedule of stock option activity | Option activity for the year ended March 31, 2021 was as follows: Shares Weighted Weighted Aggregate Options outstanding, beginning of year 646,728 $ 88.30 Granted 38,473 109.30 Exercised (165,237) 74.25 Forfeited (18,666) 105.14 Expired (1,130) 103.75 Options outstanding, end of period 500,168 $ 93.89 6.29 $ 18,080,095 Options exercisable, end of period 213,095 $ 81.47 4.11 $ 10,300,232 |
Intrinsic value of options exercised | The total intrinsic value of options exercised during the years ended March 31, 2021, 2020, and 2019 was as follows: 2021 2020 2019 $9,996,167 $5,083,094 $4,433,495 |
Summary of the status and changes restricted stock | A summary of the status of the Company’s restricted stock as of March 31, 2021 and changes during the year ended March 31, 2021, are presented below: Shares Weighted Average Fair Outstanding at March 31, 2020 705,254 $ 101.47 Granted during the period 52,735 106.28 Vested during the period (83,250) 101.17 Forfeited during the period (60,000) 100.79 Outstanding at March 31, 2021 614,739 $ 101.99 |
Share-based compensation included as a component of net income | Total stock-based compensation included as a component of net income during the years ended March 31, 2021, 2020, and 2019 was as follows: 2021 2020 2019 Stock-based compensation related to equity classified units: Stock-based compensation related to stock options $ 3,804,674 5,522,883 3,991,967 Stock-based compensation related to restricted stock 15,476,603 23,429,277 13,643,343 Total stock-based compensation related to equity classified awards $ 19,281,277 28,952,160 17,635,310 |
Acquisitions (Tables)
Acquisitions (Tables) | 12 Months Ended |
Mar. 31, 2021 | |
Business Combinations [Abstract] | |
Schedule of Business Acquisitions, by Acquisition | The following table sets forth the acquisition activity of the Company for the years ended March 31, 2021, 2020, and 2019: 2021 2020 2019 Number of branches acquired through business combinations — 38 17 Number of asset purchases 50 140 88 Total acquisitions 50 178 105 Purchase price $ 19,774,252 $ 61,555,973 $ 44,145,787 Tangible assets: Loans receivable, net 15,210,973 47,026,694 33,920,847 Property and equipment — 74,000 1,500 15,210,973 47,100,694 33,922,347 Excess of purchase prices over fair value of net tangible assets $ 4,563,279 $ 14,455,279 $ 10,223,440 Customer lists $ 4,365,779 $ 13,228,951 $ 9,688,440 Non-compete agreements 197,500 890,000 535,000 Goodwill — 336,328 — |
Fair Value (Tables)
Fair Value (Tables) | 12 Months Ended |
Mar. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Book value and estimated fair value of the Company's long-term debt | March 31, 2021 March 31, 2020 Input Level Carrying Value Estimated Fair Value Carrying Value Estimated Fair Value ASSETS Cash and cash equivalents 1 $ 15,746,454 $ 15,746,454 $ 11,618,922 $ 11,618,922 Loans receivable, net 3 733,659,389 733,659,389 804,402,786 804,402,786 LIABILITIES Senior notes payable 3 405,007,500 405,007,500 451,100,000 451,100,000 |
Fair Value Measurements, Nonrecurring | The carrying amounts and estimated fair values of amounts the Company measures at fair value on a non-recurring basis, which are limited to the Company's assets held for sale, are summarized below: March 31, 2021 March 31, 2020 Input Level Carrying Value Estimated Fair Value Carrying Value Estimated Fair Value ASSETS Assets held for sale 2 $ 1,143,528 $ 1,143,528 $ 3,991,498 $ 3,991,498 |
Quarterly Information (Unaudi_2
Quarterly Information (Unaudited) (Tables) | 12 Months Ended |
Mar. 31, 2021 | |
Quarterly Financial Information Disclosure [Abstract] | |
Schedule of quarterly financial information | The following sets forth selected quarterly operating data: Fiscal 2021 Fiscal 2020 First Second Third Fourth First Second Third Fourth (Dollars in thousands, except for earnings per share data) Total revenues $ 123,867 124,441 130,946 146,280 138,441 141,573 146,996 163,018 Provision for credit losses 25,661 26,090 28,857 5,636 41,291 52,968 55,219 32,252 General and administrative expenses 71,608 75,293 77,875 77,411 81,776 78,452 90,558 96,707 Interest expense 5,562 5,893 7,305 6,940 4,403 6,328 7,130 8,035 Income tax expense 5,527 3,767 2,418 11,409 2,363 1,312 356 2,721 Net income (loss) $ 15,509 13,398 14,491 44,884 8,608 2,513 (6,267) 23,303 Net income (loss) per common share: Basic $ 2.26 2.01 2.32 7.25 1.01 0.32 (0.87) 3.23 Diluted $ 2.24 1.96 2.25 6.96 0.97 0.31 (0.87) 3.18 |
Assets Held for Sale (Tables)
Assets Held for Sale (Tables) | 12 Months Ended |
Mar. 31, 2021 | |
Property, Plant and Equipment [Abstract] | |
Reconciles the major classes of assets held for sale | The following table reconciles the major classes of assets held for sale to the amounts presented in the Consolidated Balance Sheets: March 31, 2020 March 31, 2020 Assets held for sale: Property and equipment, net $ 1,143,528 $ 3,991,498 Total assets held for sale $ 1,143,528 $ 3,991,498 The following table reconciles the major classes of line items constituting pre-tax income of discontinued operations to the amounts presented in the Consolidated Statements of Operations: Year ended March 31, 2021 2020 2019 Revenues $ — $ — $ 9,693,367 Provision for loan losses — — 1,809,059 General and administrative expenses — — 5,542,483 Income from discontinued operations before disposal of discontinued operations and income taxes — — 2,341,825 Loss on disposal of discontinued operations — — (38,377,623) Income taxes — — 626,583 Loss from discontinued operations $ — $ — $ (36,662,381) The following table presents operating, investing and financing cash flows for the Company’s discontinued operations: Year ended March 31, 2021 2020 2019 Cash provided by operating activities: $ — $ — $ 3,553,854 Cash provided by (used in) investing activities: — — 1,138,084 Cash provided by (used in) financing activities: $ — $ — $ (17,126,000) |
Discontinued Operations (Tables
Discontinued Operations (Tables) | 12 Months Ended |
Mar. 31, 2021 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Reconciles the major classes of line items constituting pre-tax income of discontinued operations | The following table reconciles the major classes of assets held for sale to the amounts presented in the Consolidated Balance Sheets: March 31, 2020 March 31, 2020 Assets held for sale: Property and equipment, net $ 1,143,528 $ 3,991,498 Total assets held for sale $ 1,143,528 $ 3,991,498 The following table reconciles the major classes of line items constituting pre-tax income of discontinued operations to the amounts presented in the Consolidated Statements of Operations: Year ended March 31, 2021 2020 2019 Revenues $ — $ — $ 9,693,367 Provision for loan losses — — 1,809,059 General and administrative expenses — — 5,542,483 Income from discontinued operations before disposal of discontinued operations and income taxes — — 2,341,825 Loss on disposal of discontinued operations — — (38,377,623) Income taxes — — 626,583 Loss from discontinued operations $ — $ — $ (36,662,381) The following table presents operating, investing and financing cash flows for the Company’s discontinued operations: Year ended March 31, 2021 2020 2019 Cash provided by operating activities: $ — $ — $ 3,553,854 Cash provided by (used in) investing activities: — — 1,138,084 Cash provided by (used in) financing activities: $ — $ — $ (17,126,000) |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies - Additional Information (Details) | 12 Months Ended | ||
Mar. 31, 2021USD ($)branchsegments | Mar. 31, 2020USD ($)branch | Mar. 31, 2019USD ($)branch | |
Business Segments [Abstract] | |||
Number of reportable segments | segments | 1 | ||
Cash and Cash Equivalents [Abstract] | |||
Restricted cash | $ 7,000,000 | $ 5,400,000 | |
Loans and Interest Income [Abstract] | |||
Gross loans receivable | 1,104,746,261 | 1,209,871,366 | |
Impaired loans [Abstract] | |||
Bankrupt accounts that had not been charged off | 3,200,000 | ||
Maximum | |||
Loans and Interest Income [Abstract] | |||
Originations | 3,500 | 3,500 | $ 3,500 |
Small loans | |||
Loans and Interest Income [Abstract] | |||
Gross loans receivable | 620,959,979 | 761,364,753 | |
Small loans | Minimum | |||
Loans and Interest Income [Abstract] | |||
Originations | $ 250 | ||
Loan term | 4 months | ||
Small loans | Maximum | |||
Loans and Interest Income [Abstract] | |||
Originations | $ 2,450 | ||
Loan term | 30 months | ||
Large loans | |||
Loans and Interest Income [Abstract] | |||
Gross loans receivable | $ 475,470,271 | 442,683,915 | |
Large loans | Minimum | |||
Loans and Interest Income [Abstract] | |||
Originations | $ 2,500 | ||
Loan term | 12 months | ||
Large loans | Maximum | |||
Loans and Interest Income [Abstract] | |||
Originations | $ 21,400 | ||
Loan term | 48 months | ||
Sales finance loans | |||
Loans and Interest Income [Abstract] | |||
Gross loans receivable | $ 8,316,011 | $ 5,822,698 | |
Sales finance loans | Minimum | |||
Loans and Interest Income [Abstract] | |||
Originations | $ 100 | ||
Loan term | 8 months | ||
Sales finance loans | Maximum | |||
Loans and Interest Income [Abstract] | |||
Originations | $ 5,000 | ||
Loan term | 8 months | ||
United States | |||
Schedule of Subsidiaries Information [Line Items] | |||
Number of offices operated in the United States of America | branch | 1,205 | ||
Mexico | |||
Schedule of Subsidiaries Information [Line Items] | |||
Number of offices operated in the United States of America | branch | 0 | 0 |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Useful Lives (Details) | 12 Months Ended |
Mar. 31, 2021 | |
Property, Plant and Equipment [Line Items] | |
Operating lease, renewal term | 5 years |
Minimum | |
Property, Plant and Equipment [Line Items] | |
Operating lease, term of contract | 3 years |
Maximum | |
Property, Plant and Equipment [Line Items] | |
Operating lease, term of contract | 5 years |
Building | Minimum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life (in years) | 25 years |
Building | Maximum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life (in years) | 40 years |
Furniture and fixtures | Minimum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life (in years) | 5 years |
Furniture and fixtures | Maximum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life (in years) | 10 years |
Equipment | Minimum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life (in years) | 3 years |
Equipment | Maximum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life (in years) | 7 years |
Vehicles | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life (in years) | 3 years |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies - Intangible Assets (Details) | 12 Months Ended | |||||
Mar. 31, 2021USD ($)statesreporting_unit | Mar. 31, 2020USD ($) | Mar. 31, 2019USD ($) | May 12, 2020USD ($) | Apr. 01, 2020USD ($) | Mar. 31, 2018USD ($) | |
Finite-Lived Intangible Assets [Line Items] | ||||||
Number of reporting units | reporting_unit | 1 | |||||
Share Repurchases [Abstract] | ||||||
Amount authorized for repurchase | $ 30,000,000 | |||||
Amount remaining for repurchase | $ 21,400,000 | |||||
Stockholders' equity | $ 404,927,441 | $ 411,963,067 | $ 552,116,625 | $ 541,107,852 | ||
Concentration of Risk [Abstract] | ||||||
Number of states in which entity operates | states | 16 | |||||
Number of states with largest concentration of revenue | states | 4 | |||||
Advertising | $ 17,190,676 | 24,304,023 | 22,482,553 | |||
Allowance for credit losses | 91,722,288 | 96,487,856 | $ 81,519,624 | $ 66,088,139 | ||
Retained Earnings (Accumulated Deficit) | (149,336,767) | (184,748,490) | ||||
Deferred income taxes, net | 24,992,742 | $ 23,257,985 | ||||
Revolving Credit Facility | ||||||
Share Repurchases [Abstract] | ||||||
Amount outstanding | $ 405,000,000 | |||||
Revenue Benchmark | ||||||
Concentration of Risk [Abstract] | ||||||
Concentration risk percentage | 53.00% | 56.00% | 57.00% | |||
Customer lists | ||||||
Finite-Lived Intangible Assets [Line Items] | ||||||
Finite-lived intangible assets, useful life (in years) | 9 years 6 months | |||||
Customer lists | Minimum | ||||||
Finite-Lived Intangible Assets [Line Items] | ||||||
Finite-lived intangible assets, useful life (in years) | 8 years | |||||
Customer lists | Maximum | ||||||
Finite-Lived Intangible Assets [Line Items] | ||||||
Finite-lived intangible assets, useful life (in years) | 23 years | |||||
Noncompete Agreements | ||||||
Finite-Lived Intangible Assets [Line Items] | ||||||
Finite-lived intangible assets, useful life (in years) | 5 years | |||||
Noncompete Agreements | Minimum | ||||||
Finite-Lived Intangible Assets [Line Items] | ||||||
Finite-lived intangible assets, useful life (in years) | 3 years | |||||
Noncompete Agreements | Maximum | ||||||
Finite-Lived Intangible Assets [Line Items] | ||||||
Finite-lived intangible assets, useful life (in years) | 5 years 3 months 18 days | |||||
Accounting Standards Update 2016-13 | ||||||
Concentration of Risk [Abstract] | ||||||
Allowance for credit losses | $ 28,600,000 | $ 28,600,000 | ||||
Retained Earnings (Accumulated Deficit) | 21,200,000 | |||||
Deferred income taxes, net | $ 7,400,000 |
Allowance for Credit Losses a_3
Allowance for Credit Losses and Credit Quality Information (Gross Loans Receivable By Customer Tenure) (Details) - USD ($) | Mar. 31, 2021 | Apr. 01, 2020 | Mar. 31, 2020 | Mar. 31, 2019 | Mar. 31, 2018 |
Financing Receivable, Recorded Investment [Line Items] | |||||
Gross loans receivable | $ 1,104,746,261 | $ 1,209,871,366 | |||
Allowance for credit losses | 91,722,288 | $ 96,487,856 | $ 81,519,624 | $ 66,088,139 | |
Accounting Standards Update 2016-13 | |||||
Financing Receivable, Recorded Investment [Line Items] | |||||
Allowance for credit losses | 28,600,000 | $ 28,600,000 | |||
Tax Advance Loan | |||||
Financing Receivable, Recorded Investment [Line Items] | |||||
Gross loans receivable | 8,316,011 | ||||
Recency Basis | |||||
Financing Receivable, Recorded Investment [Line Items] | |||||
Gross loans receivable | 1,104,746,261 | ||||
Recency Basis | Tax Advance Loan | |||||
Financing Receivable, Recorded Investment [Line Items] | |||||
Gross loans receivable | 8,316,011 | ||||
0 to 5 months | Recency Basis | |||||
Financing Receivable, Recorded Investment [Line Items] | |||||
Gross loans receivable | 92,378,094 | ||||
0 to 5 months | Recency Basis | 30-60 days past due | |||||
Financing Receivable, Recorded Investment [Line Items] | |||||
Gross loans receivable | 92,378,097 | ||||
6 to 17 months | Recency Basis | |||||
Financing Receivable, Recorded Investment [Line Items] | |||||
Gross loans receivable | 106,742,122 | ||||
6 to 17 months | Recency Basis | 30-60 days past due | |||||
Financing Receivable, Recorded Investment [Line Items] | |||||
Gross loans receivable | 106,742,121 | ||||
18 to 35 months | Recency Basis | |||||
Financing Receivable, Recorded Investment [Line Items] | |||||
Gross loans receivable | 169,361,911 | ||||
18 to 35 months | Recency Basis | 30-60 days past due | |||||
Financing Receivable, Recorded Investment [Line Items] | |||||
Gross loans receivable | 169,361,910 | ||||
36 to 59 months | Recency Basis | |||||
Financing Receivable, Recorded Investment [Line Items] | |||||
Gross loans receivable | 130,655,627 | ||||
36 to 59 months | Recency Basis | 30-60 days past due | |||||
Financing Receivable, Recorded Investment [Line Items] | |||||
Gross loans receivable | 130,655,627 | ||||
60+ Months | Recency Basis | |||||
Financing Receivable, Recorded Investment [Line Items] | |||||
Gross loans receivable | 597,292,496 | ||||
60+ Months | Recency Basis | 30-60 days past due | |||||
Financing Receivable, Recorded Investment [Line Items] | |||||
Gross loans receivable | $ 597,292,495 |
Allowance for Credit Losses a_4
Allowance for Credit Losses and Credit Quality Information (Payment Performance On A Contractual Basis) (Details) - USD ($) | Mar. 31, 2021 | Mar. 31, 2020 |
Financing Receivable, Recorded Investment [Line Items] | ||
Gross loans receivable | $ 1,104,746,261 | $ 1,209,871,366 |
Loans | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 1,041,554,654 | |
Financing receivable, between 1 and 2 years ago | 52,109,459 | |
Financing receivable, between 2 and 3 years ago | 2,527,702 | |
Financing receivable, between 3 and 4 years ago | 202,144 | |
Financing receivable, between 4 and 5 years ago | 33,223 | |
Financing receivable, more than 5 years ago | 3,068 | |
Loans | Consumer Loan | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Gross loans receivable | 1,096,430,250 | |
Loans | 30-60 days past due | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 21,862,634 | |
Financing receivable, between 1 and 2 years ago | 2,011,261 | |
Financing receivable, between 2 and 3 years ago | 153,417 | |
Financing receivable, between 3 and 4 years ago | 21,426 | |
Financing receivable, between 4 and 5 years ago | 3,500 | |
Financing receivable, more than 5 years ago | 2,069 | |
Gross loans receivable | 24,054,307 | |
Loans | 61-90 days past due | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 18,039,010 | |
Financing receivable, between 1 and 2 years ago | 1,208,936 | |
Financing receivable, between 2 and 3 years ago | 88,119 | |
Financing receivable, between 3 and 4 years ago | 11,800 | |
Financing receivable, between 4 and 5 years ago | 571 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | 19,348,436 | |
Loans | 91 days or more past due | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 31,126,328 | |
Financing receivable, between 1 and 2 years ago | 3,120,210 | |
Financing receivable, between 2 and 3 years ago | 183,434 | |
Financing receivable, between 3 and 4 years ago | 14,028 | |
Financing receivable, between 4 and 5 years ago | 14,708 | |
Financing receivable, more than 5 years ago | 168 | |
Gross loans receivable | 34,458,876 | |
Tax Advance Loan | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 8,269,742 | |
Financing receivable, between 1 and 2 years ago | 45,292 | |
Financing receivable, between 2 and 3 years ago | 977 | |
Financing receivable, between 3 and 4 years ago | 0 | |
Financing receivable, between 4 and 5 years ago | 0 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | 8,316,011 | |
Tax Advance Loan | 30-60 days past due | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 686,667 | |
Financing receivable, between 1 and 2 years ago | 1,423 | |
Financing receivable, between 2 and 3 years ago | 0 | |
Financing receivable, between 3 and 4 years ago | 0 | |
Financing receivable, between 4 and 5 years ago | 0 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | 688,090 | |
Tax Advance Loan | 61-90 days past due | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 0 | |
Financing receivable, between 1 and 2 years ago | 0 | |
Financing receivable, between 2 and 3 years ago | 321 | |
Financing receivable, between 3 and 4 years ago | 0 | |
Financing receivable, between 4 and 5 years ago | 0 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | 321 | |
Tax Advance Loan | 91 days or more past due | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 0 | |
Financing receivable, between 1 and 2 years ago | 34,509 | |
Financing receivable, between 2 and 3 years ago | 656 | |
Financing receivable, between 3 and 4 years ago | 0 | |
Financing receivable, between 4 and 5 years ago | 0 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | 35,165 | |
Performing Financing Receivables | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Gross loans receivable | $ 1,104,130,714 | |
Performing Financing Receivables | Loans | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 970,526,682 | |
Financing receivable, between 1 and 2 years ago | 45,769,052 | |
Financing receivable, between 2 and 3 years ago | 2,102,732 | |
Financing receivable, between 3 and 4 years ago | 154,890 | |
Financing receivable, between 4 and 5 years ago | 14,444 | |
Financing receivable, more than 5 years ago | 831 | |
Performing Financing Receivables | Loans | Consumer Loan | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Gross loans receivable | 1,018,568,631 | |
Performing Financing Receivables | Tax Advance Loan | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 7,583,075 | |
Financing receivable, between 1 and 2 years ago | 9,360 | |
Financing receivable, between 2 and 3 years ago | 0 | |
Financing receivable, between 3 and 4 years ago | 0 | |
Financing receivable, between 4 and 5 years ago | 0 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | 7,592,435 | |
Contractual basis | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Gross loans receivable | 1,104,746,261 | |
Contractual basis | Loans | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 1,041,554,653 | |
Financing receivable, between 1 and 2 years ago | 52,109,459 | |
Financing receivable, between 2 and 3 years ago | 2,527,702 | |
Financing receivable, between 3 and 4 years ago | 202,145 | |
Financing receivable, between 4 and 5 years ago | 33,223 | |
Financing receivable, more than 5 years ago | 3,068 | |
Contractual basis | Loans | Consumer Loan | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Gross loans receivable | 1,096,430,250 | |
Contractual basis | Loans | 30-60 days past due | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 29,300,148 | |
Financing receivable, between 1 and 2 years ago | 1,872,816 | |
Financing receivable, between 2 and 3 years ago | 72,187 | |
Financing receivable, between 3 and 4 years ago | 1,322 | |
Financing receivable, between 4 and 5 years ago | 0 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | 31,246,473 | |
Contractual basis | Loans | 61-90 days past due | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 23,075,264 | |
Financing receivable, between 1 and 2 years ago | 1,363,196 | |
Financing receivable, between 2 and 3 years ago | 75,343 | |
Financing receivable, between 3 and 4 years ago | 567 | |
Financing receivable, between 4 and 5 years ago | 0 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | 24,514,370 | |
Contractual basis | Loans | 91 days or more past due | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 40,825,388 | |
Financing receivable, between 1 and 2 years ago | 9,211,503 | |
Financing receivable, between 2 and 3 years ago | 858,024 | |
Financing receivable, between 3 and 4 years ago | 117,183 | |
Financing receivable, between 4 and 5 years ago | 31,433 | |
Financing receivable, more than 5 years ago | 2,237 | |
Gross loans receivable | 51,045,768 | |
Contractual basis | Tax Advance Loan | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 8,269,742 | |
Financing receivable, between 1 and 2 years ago | 45,292 | |
Financing receivable, between 2 and 3 years ago | 977 | |
Financing receivable, between 3 and 4 years ago | 0 | |
Financing receivable, between 4 and 5 years ago | 0 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | 8,316,011 | |
Contractual basis | Tax Advance Loan | 30-60 days past due | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 686,667 | |
Financing receivable, between 1 and 2 years ago | 0 | |
Financing receivable, between 2 and 3 years ago | 0 | |
Financing receivable, between 3 and 4 years ago | 0 | |
Financing receivable, between 4 and 5 years ago | 0 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | 686,667 | |
Contractual basis | Tax Advance Loan | 61-90 days past due | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 0 | |
Financing receivable, between 1 and 2 years ago | 0 | |
Financing receivable, between 2 and 3 years ago | 0 | |
Financing receivable, between 3 and 4 years ago | 0 | |
Financing receivable, between 4 and 5 years ago | 0 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | 0 | |
Contractual basis | Tax Advance Loan | 91 days or more past due | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 0 | |
Financing receivable, between 1 and 2 years ago | 45,292 | |
Financing receivable, between 2 and 3 years ago | 977 | |
Financing receivable, between 3 and 4 years ago | 0 | |
Financing receivable, between 4 and 5 years ago | 0 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | 46,269 | |
Contractual basis | Performing Financing Receivables | Loans | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 948,353,853 | |
Financing receivable, between 1 and 2 years ago | 39,661,944 | |
Financing receivable, between 2 and 3 years ago | 1,522,148 | |
Financing receivable, between 3 and 4 years ago | 83,073 | |
Financing receivable, between 4 and 5 years ago | 1,790 | |
Financing receivable, more than 5 years ago | 831 | |
Contractual basis | Performing Financing Receivables | Loans | Consumer Loan | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Gross loans receivable | 989,623,639 | |
Contractual basis | Performing Financing Receivables | Tax Advance Loan | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 7,583,075 | |
Financing receivable, between 1 and 2 years ago | 0 | |
Financing receivable, between 2 and 3 years ago | 0 | |
Financing receivable, between 3 and 4 years ago | 0 | |
Financing receivable, between 4 and 5 years ago | 0 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | $ 7,583,075 |
Allowance for Credit Losses a_5
Allowance for Credit Losses and Credit Quality Information (Summary of Past Due Receivables) (Details) - USD ($) | Mar. 31, 2021 | Mar. 31, 2020 |
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Loans | $ 1,104,746,261 | $ 1,209,871,366 |
Unearned interest, insurance and fees | 279,364,584 | 308,980,724 |
Total net loans | 900,890,642 | |
Tax Advance Loan | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Loans | 8,316,011 | |
Performing Financing Receivables | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Loans | $ 1,104,130,714 | |
Recency Basis | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Loans | 1,104,746,261 | |
Unearned interest, insurance and fees | (279,364,584) | |
Total net loans | $ 825,381,677 | |
Financing receivable, percent past due | 7.10% | 10.50% |
Recency Basis | Tax Advance Loan | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Loans | $ 8,316,011 | |
Recency Basis | 0 to 5 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Loans | 92,378,094 | |
Recency Basis | 6 to 17 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Loans | 106,742,122 | |
Recency Basis | 18 to 35 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Loans | 169,361,911 | |
Recency Basis | 36 to 59 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Loans | 130,655,627 | |
Recency Basis | 60+ Months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Loans | 597,292,496 | |
Recency Basis | Performing Financing Receivables | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Current | 1,026,161,065 | |
Unearned interest, insurance and fees | (259,492,219) | |
Total net loans | 766,668,846 | |
Recency Basis | Performing Financing Receivables | Tax Advance Loan | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Current | 7,592,435 | |
Recency Basis | Performing Financing Receivables | 0 to 5 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Current | 72,702,970 | |
Recency Basis | Performing Financing Receivables | 6 to 17 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Current | 94,466,209 | |
Recency Basis | Performing Financing Receivables | 18 to 35 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Current | 158,217,605 | |
Recency Basis | Performing Financing Receivables | 36 to 59 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Current | 123,542,346 | |
Recency Basis | Performing Financing Receivables | 60+ Months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Current | 569,639,500 | |
Recency Basis | 30-60 days past due | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 24,742,398 | $ 48,206,910 |
Unearned interest, insurance and fees | (6,256,776) | |
Total net loans | $ 18,485,622 | |
Financing receivable, percent past due | 2.20% | |
Recency Basis | 30-60 days past due | Tax Advance Loan | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | $ 688,090 | |
Recency Basis | 30-60 days past due | 0 to 5 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 4,799,102 | |
Total Loans | 92,378,097 | |
Recency Basis | 30-60 days past due | 6 to 17 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 3,187,347 | |
Total Loans | 106,742,121 | |
Recency Basis | 30-60 days past due | 18 to 35 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 3,570,696 | |
Total Loans | 169,361,910 | |
Recency Basis | 30-60 days past due | 36 to 59 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 2,432,489 | |
Total Loans | 130,655,627 | |
Recency Basis | 30-60 days past due | 60+ Months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 10,064,674 | |
Total Loans | 597,292,495 | |
Recency Basis | 61-90 days past due | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 19,348,757 | 28,450,942 |
Unearned interest, insurance and fees | (4,892,850) | |
Total net loans | $ 14,455,907 | |
Financing receivable, percent past due | 1.80% | |
Recency Basis | 61-90 days past due | Tax Advance Loan | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | $ 321 | |
Recency Basis | 61-90 days past due | 0 to 5 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 5,680,380 | |
Recency Basis | 61-90 days past due | 6 to 17 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 2,798,411 | |
Recency Basis | 61-90 days past due | 18 to 35 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 2,592,402 | |
Recency Basis | 61-90 days past due | 36 to 59 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 1,753,291 | |
Recency Basis | 61-90 days past due | 60+ Months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 6,523,952 | |
Recency Basis | 91 days or more past due | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 34,494,041 | 50,669,837 |
Unearned interest, insurance and fees | (8,722,739) | |
Total net loans | $ 25,771,302 | |
Financing receivable, percent past due | 3.10% | |
Recency Basis | 91 days or more past due | Tax Advance Loan | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | $ 35,165 | |
Recency Basis | 91 days or more past due | 0 to 5 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 9,195,642 | |
Recency Basis | 91 days or more past due | 6 to 17 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 6,290,155 | |
Recency Basis | 91 days or more past due | 18 to 35 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 4,981,208 | |
Recency Basis | 91 days or more past due | 36 to 59 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 2,927,501 | |
Recency Basis | 91 days or more past due | 60+ Months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 11,064,370 | |
Recency Basis | Total | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 78,585,196 | $ 127,327,689 |
Unearned interest, insurance and fees | (19,872,365) | |
Total net loans | 58,712,831 | |
Recency Basis | Total | Tax Advance Loan | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 723,576 | |
Recency Basis | Total | 0 to 5 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 19,675,124 | |
Recency Basis | Total | 6 to 17 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 12,275,913 | |
Recency Basis | Total | 18 to 35 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 11,144,306 | |
Recency Basis | Total | 36 to 59 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 7,113,281 | |
Recency Basis | Total | 60+ Months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 27,652,996 | |
Contractual basis | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Loans | 1,104,746,261 | |
Unearned interest, insurance and fees | (279,364,584) | |
Total net loans | $ 825,381,677 | |
Financing receivable, percent past due | 9.70% | 12.80% |
Contractual basis | Tax Advance Loan | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Loans | $ 8,316,011 | |
Contractual basis | 0 to 5 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Loans | 92,378,095 | |
Contractual basis | 6 to 17 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Loans | 106,742,121 | |
Contractual basis | 18 to 35 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Loans | 169,361,910 | |
Contractual basis | 36 to 59 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Loans | 130,655,628 | |
Contractual basis | 60+ Months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Total Loans | 597,292,496 | |
Contractual basis | Performing Financing Receivables | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Current | 997,206,715 | |
Unearned interest, insurance and fees | (252,170,339) | |
Total net loans | 745,036,376 | |
Contractual basis | Performing Financing Receivables | Tax Advance Loan | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Current | 7,583,075 | |
Contractual basis | Performing Financing Receivables | 0 to 5 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Current | 70,532,439 | |
Contractual basis | Performing Financing Receivables | 6 to 17 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Current | 90,679,304 | |
Contractual basis | Performing Financing Receivables | 18 to 35 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Current | 153,922,334 | |
Contractual basis | Performing Financing Receivables | 36 to 59 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Current | 120,168,698 | |
Contractual basis | Performing Financing Receivables | 60+ Months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Current | 554,320,865 | |
Contractual basis | 30-60 days past due | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 31,933,140 | $ 49,137,102 |
Unearned interest, insurance and fees | (8,075,147) | |
Total net loans | $ 23,857,993 | |
Financing receivable, percent past due | 2.90% | |
Contractual basis | 30-60 days past due | Tax Advance Loan | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | $ 686,667 | |
Contractual basis | 30-60 days past due | 0 to 5 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 5,245,878 | |
Contractual basis | 30-60 days past due | 6 to 17 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 3,936,937 | |
Contractual basis | 30-60 days past due | 18 to 35 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 4,471,202 | |
Contractual basis | 30-60 days past due | 36 to 59 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 3,229,253 | |
Contractual basis | 30-60 days past due | 60+ Months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 14,363,203 | |
Contractual basis | 61-90 days past due | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 24,514,370 | 35,020,925 |
Unearned interest, insurance and fees | (6,199,113) | |
Total net loans | $ 18,315,257 | |
Financing receivable, percent past due | 2.20% | |
Contractual basis | 61-90 days past due | Tax Advance Loan | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | $ 0 | |
Contractual basis | 61-90 days past due | 0 to 5 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 6,019,264 | |
Contractual basis | 61-90 days past due | 6 to 17 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 3,267,446 | |
Contractual basis | 61-90 days past due | 18 to 35 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 3,488,629 | |
Contractual basis | 61-90 days past due | 36 to 59 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 2,337,625 | |
Contractual basis | 61-90 days past due | 60+ Months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 9,401,406 | |
Contractual basis | 91 days or more past due | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 51,092,036 | 70,719,727 |
Unearned interest, insurance and fees | (12,919,985) | |
Total net loans | $ 38,172,051 | |
Financing receivable, percent past due | 4.60% | |
Contractual basis | 91 days or more past due | Tax Advance Loan | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | $ 46,269 | |
Contractual basis | 91 days or more past due | 0 to 5 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 10,580,514 | |
Contractual basis | 91 days or more past due | 6 to 17 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 8,858,434 | |
Contractual basis | 91 days or more past due | 18 to 35 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 7,479,745 | |
Contractual basis | 91 days or more past due | 36 to 59 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 4,920,052 | |
Contractual basis | 91 days or more past due | 60+ Months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 19,207,022 | |
Contractual basis | Total | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 107,539,546 | $ 154,877,754 |
Unearned interest, insurance and fees | (27,194,245) | |
Total net loans | 80,345,301 | |
Contractual basis | Total | Tax Advance Loan | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 732,936 | |
Contractual basis | Total | 0 to 5 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 21,845,656 | |
Contractual basis | Total | 6 to 17 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 16,062,817 | |
Contractual basis | Total | 18 to 35 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 15,439,576 | |
Contractual basis | Total | 36 to 59 months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | 10,486,930 | |
Contractual basis | Total | 60+ Months | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | $ 42,971,631 |
Allowance for Credit Losses a_6
Allowance for Credit Losses and Credit Quality Information (Nonaccrual) (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2021 | Mar. 31, 2020 | |
Financing Receivable, Nonaccrual [Line Items] | |||
Uncollected accrued interest reversed | $ 6,200,000 | $ 22,400,000 | |
Financing receivable, nonaccrual | 61,731,356 | 61,731,356 | $ 83,126,604 |
Financing receivable, nonaccrual, no allowance | 0 | 0 | |
Interest Income Recognized | 14,690,456 | ||
Nonaccrual status | |||
Financing Receivable, Nonaccrual [Line Items] | |||
Unearned interest, insurance and fees | (20,894,036) | (20,894,036) | (28,510,140) |
61-90 days past due | |||
Financing Receivable, Nonaccrual [Line Items] | |||
Financing receivable, nonaccrual | 0 | 0 | |
Tax Advance Loan | |||
Financing Receivable, Nonaccrual [Line Items] | |||
Financing receivable, nonaccrual | 46,269 | 46,269 | 41,573 |
Financing receivable, nonaccrual, no allowance | 0 | 0 | |
Tax Advance Loan | 61-90 days past due | |||
Financing Receivable, Nonaccrual [Line Items] | |||
Financing receivable, nonaccrual | 0 | 0 | |
0 to 5 months | |||
Financing Receivable, Nonaccrual [Line Items] | |||
Financing receivable, nonaccrual | 17,191,922 | 17,191,922 | 26,040,593 |
Financing receivable, nonaccrual, no allowance | 0 | 0 | |
Interest Income Recognized | 1,705,371 | ||
0 to 5 months | 61-90 days past due | |||
Financing Receivable, Nonaccrual [Line Items] | |||
Financing receivable, nonaccrual | 0 | 0 | |
6 to 17 months | |||
Financing Receivable, Nonaccrual [Line Items] | |||
Financing receivable, nonaccrual | 13,211,641 | 13,211,641 | 17,466,450 |
Financing receivable, nonaccrual, no allowance | 0 | 0 | |
Interest Income Recognized | 2,433,144 | ||
6 to 17 months | 61-90 days past due | |||
Financing Receivable, Nonaccrual [Line Items] | |||
Financing receivable, nonaccrual | 0 | 0 | |
18 to 35 months | |||
Financing Receivable, Nonaccrual [Line Items] | |||
Financing receivable, nonaccrual | 12,088,377 | 12,088,377 | 13,723,295 |
Financing receivable, nonaccrual, no allowance | 0 | 0 | |
Interest Income Recognized | 2,195,160 | ||
18 to 35 months | 61-90 days past due | |||
Financing Receivable, Nonaccrual [Line Items] | |||
Financing receivable, nonaccrual | 0 | 0 | |
36 to 59 months | |||
Financing Receivable, Nonaccrual [Line Items] | |||
Financing receivable, nonaccrual | 8,161,951 | 8,161,951 | 10,071,288 |
Financing receivable, nonaccrual, no allowance | 0 | 0 | |
Interest Income Recognized | 1,609,059 | ||
36 to 59 months | 61-90 days past due | |||
Financing Receivable, Nonaccrual [Line Items] | |||
Financing receivable, nonaccrual | 0 | 0 | |
60+ Months | |||
Financing Receivable, Nonaccrual [Line Items] | |||
Financing receivable, nonaccrual | 31,925,232 | 31,925,232 | $ 44,293,545 |
Financing receivable, nonaccrual, no allowance | 0 | 0 | |
Interest Income Recognized | 6,747,722 | ||
60+ Months | 61-90 days past due | |||
Financing Receivable, Nonaccrual [Line Items] | |||
Financing receivable, nonaccrual | $ 0 | $ 0 |
Allowance for Credit Losses a_7
Allowance for Credit Losses and Credit Quality Information (Rollforward of Allowance For Loan Losses) (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |||||||||
Mar. 31, 2021 | Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Sep. 30, 2019 | Jun. 30, 2019 | Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||||||||||
Beginning balance | $ 96,487,856 | $ 81,519,624 | $ 96,487,856 | $ 81,519,624 | $ 66,088,139 | ||||||
Provision for credit losses | $ 5,636,000 | $ 28,857,000 | $ 26,090,000 | 25,661,000 | $ 32,252,000 | $ 55,219,000 | $ 52,968,000 | 41,291,000 | 86,244,714 | 181,730,182 | 148,426,578 |
Loan losses | (141,270,125) | (183,439,199) | (148,308,199) | ||||||||
Recoveries | 21,631,475 | 16,677,249 | 15,313,106 | ||||||||
Ending Balance | $ 91,722,288 | 96,487,856 | 91,722,288 | 96,487,856 | 81,519,624 | ||||||
Impact of ASC 326 adoption | |||||||||||
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||||||||||
Beginning balance | $ 28,628,368 | $ 0 | $ 28,628,368 | 0 | 0 | ||||||
Ending Balance | $ 28,628,368 | $ 28,628,368 | $ 0 |
Allowance for Credit Losses a_8
Allowance for Credit Losses and Credit Quality Information (Summary of Impairment) (Details) - USD ($) | Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | Mar. 31, 2018 |
Summary of loans individually and collectively evaluated for impairment [Abstract] | ||||
Gross loans in bankruptcy, excluding contractually delinquent | $ 5,165,752 | |||
Gross loans contractually delinquent | 70,719,727 | |||
Loans not contractually delinquent and not in bankruptcy | 1,133,985,887 | |||
Gross loan balance | $ 1,104,746,261 | 1,209,871,366 | ||
Unearned interest and fees | (308,980,724) | |||
Net loans | 900,890,642 | |||
Allowance for credit losses | $ (91,722,288) | (96,487,856) | $ (81,519,624) | $ (66,088,139) |
Loans, net of allowance for loan losses | 804,402,786 | |||
Loans individually evaluated for impairment (impaired loans) | ||||
Summary of loans individually and collectively evaluated for impairment [Abstract] | ||||
Gross loans in bankruptcy, excluding contractually delinquent | 5,165,752 | |||
Gross loans contractually delinquent | 70,719,727 | |||
Loans not contractually delinquent and not in bankruptcy | 0 | |||
Gross loan balance | 75,885,479 | |||
Unearned interest and fees | (16,848,762) | |||
Net loans | 59,036,717 | |||
Allowance for credit losses | (54,090,509) | |||
Loans, net of allowance for loan losses | 4,946,208 | |||
Loans collectively evaluated for impairment | ||||
Summary of loans individually and collectively evaluated for impairment [Abstract] | ||||
Gross loans in bankruptcy, excluding contractually delinquent | 0 | |||
Gross loans contractually delinquent | 0 | |||
Loans not contractually delinquent and not in bankruptcy | 1,133,985,887 | |||
Gross loan balance | 1,133,985,887 | |||
Unearned interest and fees | (292,131,962) | |||
Net loans | 841,853,925 | |||
Allowance for credit losses | (42,397,347) | |||
Loans, net of allowance for loan losses | $ 799,456,578 |
Allowance for Credit Losses a_9
Allowance for Credit Losses and Credit Quality Information (Payment Performance On A Recency Basis) (Details) - USD ($) | Mar. 31, 2021 | Mar. 31, 2020 |
Financing Receivable, Recorded Investment [Line Items] | ||
Gross loans receivable | $ 1,104,746,261 | $ 1,209,871,366 |
Loans | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 1,041,554,654 | |
Financing receivable, between 1 and 2 years ago | 52,109,459 | |
Financing receivable, between 2 and 3 years ago | 2,527,702 | |
Financing receivable, between 3 and 4 years ago | 202,144 | |
Financing receivable, between 4 and 5 years ago | 33,223 | |
Financing receivable, more than 5 years ago | 3,068 | |
Loans | Consumer Loan | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Gross loans receivable | 1,096,430,250 | |
Loans | 30-60 days past due | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 21,862,634 | |
Financing receivable, between 1 and 2 years ago | 2,011,261 | |
Financing receivable, between 2 and 3 years ago | 153,417 | |
Financing receivable, between 3 and 4 years ago | 21,426 | |
Financing receivable, between 4 and 5 years ago | 3,500 | |
Financing receivable, more than 5 years ago | 2,069 | |
Gross loans receivable | 24,054,307 | |
Loans | 61-90 days past due | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 18,039,010 | |
Financing receivable, between 1 and 2 years ago | 1,208,936 | |
Financing receivable, between 2 and 3 years ago | 88,119 | |
Financing receivable, between 3 and 4 years ago | 11,800 | |
Financing receivable, between 4 and 5 years ago | 571 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | 19,348,436 | |
Loans | 91 days or more past due | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 31,126,328 | |
Financing receivable, between 1 and 2 years ago | 3,120,210 | |
Financing receivable, between 2 and 3 years ago | 183,434 | |
Financing receivable, between 3 and 4 years ago | 14,028 | |
Financing receivable, between 4 and 5 years ago | 14,708 | |
Financing receivable, more than 5 years ago | 168 | |
Gross loans receivable | 34,458,876 | |
Tax Advance Loan | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 8,269,742 | |
Financing receivable, between 1 and 2 years ago | 45,292 | |
Financing receivable, between 2 and 3 years ago | 977 | |
Financing receivable, between 3 and 4 years ago | 0 | |
Financing receivable, between 4 and 5 years ago | 0 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | 8,316,011 | |
Tax Advance Loan | 30-60 days past due | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 686,667 | |
Financing receivable, between 1 and 2 years ago | 1,423 | |
Financing receivable, between 2 and 3 years ago | 0 | |
Financing receivable, between 3 and 4 years ago | 0 | |
Financing receivable, between 4 and 5 years ago | 0 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | 688,090 | |
Tax Advance Loan | 61-90 days past due | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 0 | |
Financing receivable, between 1 and 2 years ago | 0 | |
Financing receivable, between 2 and 3 years ago | 321 | |
Financing receivable, between 3 and 4 years ago | 0 | |
Financing receivable, between 4 and 5 years ago | 0 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | 321 | |
Tax Advance Loan | 91 days or more past due | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 0 | |
Financing receivable, between 1 and 2 years ago | 34,509 | |
Financing receivable, between 2 and 3 years ago | 656 | |
Financing receivable, between 3 and 4 years ago | 0 | |
Financing receivable, between 4 and 5 years ago | 0 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | 35,165 | |
Performing Financing Receivables | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Gross loans receivable | $ 1,104,130,714 | |
Performing Financing Receivables | Loans | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 970,526,682 | |
Financing receivable, between 1 and 2 years ago | 45,769,052 | |
Financing receivable, between 2 and 3 years ago | 2,102,732 | |
Financing receivable, between 3 and 4 years ago | 154,890 | |
Financing receivable, between 4 and 5 years ago | 14,444 | |
Financing receivable, more than 5 years ago | 831 | |
Performing Financing Receivables | Loans | Consumer Loan | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Gross loans receivable | 1,018,568,631 | |
Performing Financing Receivables | Tax Advance Loan | ||
Financing Receivable, Recorded Investment [Line Items] | ||
Financing receivable, up to 1 year ago | 7,583,075 | |
Financing receivable, between 1 and 2 years ago | 9,360 | |
Financing receivable, between 2 and 3 years ago | 0 | |
Financing receivable, between 3 and 4 years ago | 0 | |
Financing receivable, between 4 and 5 years ago | 0 | |
Financing receivable, more than 5 years ago | 0 | |
Gross loans receivable | $ 7,592,435 |
Allowance for Credit Losses _10
Allowance for Credit Losses and Credit Quality Information (Assessment of Credit Quality) (Details) - USD ($) | 12 Months Ended | ||
Mar. 31, 2020 | Mar. 31, 2019 | Mar. 31, 2021 | |
Financing Receivable, Recorded Investment [Line Items] | |||
Impaired loans | $ 57,200,000 | $ 47,000,000 | |
Gross loans receivable | 1,209,871,366 | $ 1,104,746,261 | |
New borrower | |||
Financing Receivable, Recorded Investment [Line Items] | |||
Gross loans receivable | 124,800,193 | ||
Former borrower | |||
Financing Receivable, Recorded Investment [Line Items] | |||
Gross loans receivable | 127,108,125 | ||
Refinance | |||
Financing Receivable, Recorded Investment [Line Items] | |||
Gross loans receivable | 935,448,882 | ||
Delinquent refinance | |||
Financing Receivable, Recorded Investment [Line Items] | |||
Gross loans receivable | 22,514,166 | ||
Performing Financing Receivables | |||
Financing Receivable, Recorded Investment [Line Items] | |||
Gross loans receivable | 1,104,130,714 | ||
Nonperforming Financing Receivables | |||
Financing Receivable, Recorded Investment [Line Items] | |||
Gross loans receivable | 105,740,652 | ||
Consumer loans- non-bankrupt accounts | |||
Financing Receivable, Recorded Investment [Line Items] | |||
Gross loans receivable | 1,203,552,152 | ||
Consumer loans- bankrupt accounts | |||
Financing Receivable, Recorded Investment [Line Items] | |||
Gross loans receivable | $ 6,319,214 |
Allowance for Credit Losses _11
Allowance for Credit Losses and Credit Quality Information (Summary of Past Due Receivables) (Details) - USD ($) | Mar. 31, 2021 | Mar. 31, 2020 |
Contractual basis | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, percent past due | 9.70% | 12.80% |
Contractual basis | 30-60 days past due | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, percent past due | 2.90% | |
Financing receivable, past due | $ 31,933,140 | $ 49,137,102 |
Contractual basis | 61-90 days past due | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, percent past due | 2.20% | |
Financing receivable, past due | $ 24,514,370 | 35,020,925 |
Contractual basis | 91 days or more past due | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, percent past due | 4.60% | |
Financing receivable, past due | $ 51,092,036 | 70,719,727 |
Contractual basis | Total | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | $ 107,539,546 | $ 154,877,754 |
Recency Basis | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, percent past due | 7.10% | 10.50% |
Recency Basis | 30-60 days past due | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, percent past due | 2.20% | |
Financing receivable, past due | $ 24,742,398 | $ 48,206,910 |
Recency Basis | 61-90 days past due | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, percent past due | 1.80% | |
Financing receivable, past due | $ 19,348,757 | 28,450,942 |
Recency Basis | 91 days or more past due | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, percent past due | 3.10% | |
Financing receivable, past due | $ 34,494,041 | 50,669,837 |
Recency Basis | Total | ||
Financing Receivable, Recorded Investment, Past Due [Line Items] | ||
Financing receivable, past due | $ 78,585,196 | $ 127,327,689 |
Property and Equipment (Details
Property and Equipment (Details) - USD ($) | 12 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, gross | $ 72,718,010 | $ 68,525,287 | |
Less accumulated depreciation and amortization | (46,377,973) | (43,764,179) | |
Total | 26,340,037 | 24,761,108 | |
Depreciation | 6,945,581 | 7,147,966 | $ 6,608,348 |
Land | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, gross | 100,443 | 100,443 | |
Building and leasehold improvements | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, gross | 17,882,214 | 17,048,098 | |
Furniture and equipment | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, gross | $ 54,735,353 | $ 51,376,746 |
Intangible Assets (Details)
Intangible Assets (Details) - USD ($) | Mar. 31, 2021 | Mar. 31, 2020 |
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | $ 65,029,892 | $ 60,466,612 |
Accumulated Amortization | (41,492,375) | (36,018,135) |
Net Intangible Asset | 23,537,517 | 24,448,477 |
Estimated amortization expense for intangible assets for future years [Abstract] | ||
2022 | 4,800,000 | |
2023 | 4,200,000 | |
2024 | 4,000,000 | |
2025 | 3,700,000 | |
2026 | 3,100,000 | |
Thereafter | 3,800,000 | |
Cost of acquiring existing customers | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 54,777,749 | 50,411,969 |
Accumulated Amortization | (32,322,607) | (27,215,464) |
Net Intangible Asset | 22,455,142 | 23,196,505 |
Noncompete Agreements | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 10,252,143 | 10,054,643 |
Accumulated Amortization | (9,169,768) | (8,802,671) |
Net Intangible Asset | $ 1,082,375 | $ 1,251,972 |
Goodwill (Details)
Goodwill (Details) - USD ($) | 12 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Balance at beginning of year: | |||
Goodwill | $ 7,450,422 | $ 7,114,094 | |
Accumulated goodwill impairment losses | (79,631) | (79,631) | |
Goodwill, net | 7,370,791 | 7,370,791 | $ 7,034,463 |
Goodwill acquired during the year | 0 | 336,328 | |
Impairment losses | 0 | 0 | |
Balance at end of year: | |||
Goodwill | 7,450,422 | 7,450,422 | |
Accumulated goodwill impairment losses | (79,631) | (79,631) | |
Goodwill, net | $ 7,370,791 | $ 7,370,791 | $ 7,034,463 |
Notes Payable (Details)
Notes Payable (Details) | 3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | ||
Mar. 31, 2021USD ($) | Sep. 30, 2020 | Dec. 31, 2020USD ($) | Mar. 31, 2021USD ($) | Mar. 31, 2020USD ($) | Mar. 31, 2019USD ($) | |
Line of Credit Facility [Line Items] | ||||||
Accordion feature permitting the maximum aggregate commitments to increase | $ 685,000,000 | $ 685,000,000 | ||||
Standby letters of credit | $ 300,000 | $ 300,000 | ||||
Extension period | 1 year | |||||
Commitment fee percentage | 0.50% | |||||
Unused borrowing capacity fee | $ 1,300,000 | $ 1,000,000 | $ 1,100,000 | |||
Effective interest rate | 5.80% | 5.80% | 5.80% | 6.70% | ||
Revolving Credit Facility | ||||||
Line of Credit Facility [Line Items] | ||||||
Maximum borrowing capacity | $ 685,000,000 | $ 685,000,000 | ||||
Amount outstanding | 405,000,000 | $ 405,000,000 | ||||
Expiration date | Jun. 7, 2024 | |||||
Unused amount available | 181,400,000 | $ 181,400,000 | ||||
Minimum net worth | $ 325,000,000 | $ 365,000,000 | ||||
Fixed conversion ratio | 2.75 | 2.25 | ||||
Maximum ratio to total debt | 2 | |||||
Maximum collateral performance indicator percentage | 24.00% | |||||
Expiration period | 60 days | |||||
Minimum | ||||||
Line of Credit Facility [Line Items] | ||||||
Interest rate | 3.50% | 3.50% | ||||
Maximum | ||||||
Line of Credit Facility [Line Items] | ||||||
Interest rate | 4.50% | 4.50% |
Notes Payable (Debt Maturities)
Notes Payable (Debt Maturities) (Details) | Mar. 31, 2021USD ($) |
Aggregate annual maturities of notes payable [Abstract] | |
2022 | $ 0 |
2023 | 0 |
2024 | 0 |
2025 | 405,007,500 |
2026 | 0 |
Total future debt payments | $ 405,007,500 |
Insurance and Other Income (Det
Insurance and Other Income (Details) - USD ($) | 12 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Components of Other Income [Line Items] | |||
Insurance and other income | $ 74,419,765 | $ 81,702,244 | $ 75,388,648 |
Insurance commissions | |||
Components of Other Income [Line Items] | |||
Insurance and other income | 44,214,454 | 50,360,730 | 45,182,596 |
Tax return preparation revenue | |||
Components of Other Income [Line Items] | |||
Insurance and other income | 18,098,087 | 20,936,447 | 21,454,117 |
Auto club membership revenue | |||
Components of Other Income [Line Items] | |||
Insurance and other income | 7,863,145 | 6,254,748 | 4,452,018 |
Other | |||
Components of Other Income [Line Items] | |||
Insurance and other income | $ 4,244,079 | $ 4,150,319 | $ 4,299,917 |
Insurance and Other Income (Rei
Insurance and Other Income (Reinsurance Contracts) (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Insurance Commissions and other income [Abstract] | |||
Net written premiums | $ 5.9 | $ 6.6 | $ 5.6 |
Earned premiums | 6 | 6.2 | $ 5.7 |
Cash reserves | $ 4 | $ 4.7 |
Non-filing Insurance (Details)
Non-filing Insurance (Details) - USD ($) | 12 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Non-file Insurance [Abstract] | |||
Insurance premiums written | $ 7,072,647 | $ 8,251,927 | $ 6,164,871 |
Recoveries on claims paid | 959,620 | 1,001,288 | 996,482 |
Claims paid | $ 5,223,484 | $ 7,570,126 | $ 6,553,271 |
Leases (Details)
Leases (Details) | Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 |
Operating Leased Assets [Line Items] | |||
Effective interest rate | 5.80% | 5.80% | 6.70% |
Minimum | |||
Operating Leased Assets [Line Items] | |||
Operating lease, term of contract | 3 years | ||
Maximum | |||
Operating Leased Assets [Line Items] | |||
Operating lease, term of contract | 5 years |
Leases (Lease Cost) (Details)
Leases (Lease Cost) (Details) - USD ($) | 12 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Operating Leases [Abstract] | ||
Operating lease cost | $ 27,977,226 | $ 26,244,323 |
Short-term lease cost | 1,800 | 4,500 |
Variable lease cost | 3,621,748 | 3,376,275 |
Total lease cost | 31,600,774 | 29,625,098 |
Cash paid for amounts included in the measurement of lease liabilities | 27,559,260 | 25,618,886 |
Right-of-use assets obtained in exchange for new operating lease liabilities | $ 12,482,167 | $ 36,826,045 |
Weighted average remaining lease term — operating leases | 7 years 3 months 18 days | 8 years 4 months 24 days |
Weighted-average discount rate — operating leases | 6.30% | 6.70% |
Leases (Maturities Of Operating
Leases (Maturities Of Operating Lease ) (Details) - USD ($) | Mar. 31, 2021 | Mar. 31, 2020 |
Leases [Abstract] | ||
FY2022 | $ 25,697,140 | |
FY2023 | 21,366,591 | |
FY2024 | 17,262,768 | |
FY2025 | 12,608,028 | |
FY2026 | 8,874,883 | |
Thereafter | 31,311,884 | |
Total undiscounted lease liability | 117,121,294 | |
Imputed interest | 25,403,219 | |
Total discounted lease liability | $ 91,718,075 | $ 102,759,386 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||||||
Mar. 31, 2021 | Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Sep. 30, 2019 | Jun. 30, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Income Tax Contingency [Line Items] | |||||||||||||
Tax expenses | $ 850,000 | $ 10,500,000 | |||||||||||
Income tax expense | $ 11,409,000 | $ 2,418,000 | $ 3,767,000 | $ 5,527,000 | $ 2,721,000 | $ 356,000 | $ 1,312,000 | $ 2,363,000 | $ 23,120,599 | $ 6,751,965 | $ 15,981,057 | ||
U.S. federal income tax rate (in hundredths) | 21.00% | ||||||||||||
Increased deferred tax asset valuation allowance | 144,125 | $ 7,900,000 | |||||||||||
State net operating loss carryforwards | 78,358 | 387,558 | 78,358 | 387,558 | |||||||||
Valuation allowance | 11,184,384 | 11,040,259 | 11,184,384 | 11,040,259 | |||||||||
Foreign tax credit carryforward | 3,254,926 | 3,254,926 | 3,254,926 | 3,254,926 | |||||||||
Total gross unrecognized tax benefits including interest | 3,100,000 | 5,800,000 | 3,100,000 | 5,800,000 | 5,800,000 | ||||||||
Unrecognized tax benefits that are permanent in nature and, if recognized, would affect the annual effective tax rate | 2,600,000 | 5,200,000 | 2,600,000 | 5,200,000 | 5,400,000 | ||||||||
Gross unrecognized tax benefit expected to resolved | 700,000 | 700,000 | |||||||||||
Accrued gross interest | 1,200,000 | 1,400,000 | 1,200,000 | 1,400,000 | 1,800,000 | ||||||||
Current period gross interest expense | 300,000 | (100,000) | 1,100,000 | ||||||||||
Capital loss carryforward | 7,928,184 | 7,784,059 | 7,928,184 | 7,784,059 | |||||||||
Other loss carryforward | 700,000 | 700,000 | |||||||||||
Discontinued Operations, Disposed of by Sale | |||||||||||||
Income Tax Contingency [Line Items] | |||||||||||||
Income tax expense | 0 | 0 | $ 626,583 | ||||||||||
Domestic Tax Authority | |||||||||||||
Income Tax Contingency [Line Items] | |||||||||||||
Operating loss carryforwards | 2,200,000 | 2,200,000 | |||||||||||
Operating loss subject to expiration | 1,000 | 1,000 | |||||||||||
Colorado | Domestic Tax Authority | |||||||||||||
Income Tax Contingency [Line Items] | |||||||||||||
Operating loss subject to expiration | 54,318 | 54,318 | |||||||||||
Valuation allowance | $ 1,274 | $ 1,274 | |||||||||||
Mexico | |||||||||||||
Income Tax Contingency [Line Items] | |||||||||||||
Tax expenses | $ 4,900,000 | ||||||||||||
Capital loss carryforward | $ 37,100,000 | $ 37,100,000 |
Income Taxes (Income Tax Expens
Income Taxes (Income Tax Expense Benefit) (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |||||||||
Mar. 31, 2021 | Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Sep. 30, 2019 | Jun. 30, 2019 | Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Deferred Income Tax Expense (Benefit) [Abstract] | |||||||||||
Deferred income tax benefit | $ 5,651,362 | $ 572,914 | $ (3,655,751) | ||||||||
Income Tax Expense (Benefit) [Abstract] | |||||||||||
Income tax expenses (benefit) | $ 11,409,000 | $ 2,418,000 | $ 3,767,000 | $ 5,527,000 | $ 2,721,000 | $ 356,000 | $ 1,312,000 | $ 2,363,000 | 23,120,599 | 6,751,965 | 15,981,057 |
Discontinued Operations, Disposed of by Sale | |||||||||||
Income Tax Expense (Benefit) [Abstract] | |||||||||||
Income tax expenses (benefit) | 0 | 0 | 626,583 | ||||||||
Continuing Operations | |||||||||||
Current Income Tax Expense (Benefit) [Abstract] | |||||||||||
U.S. Federal | 16,443,592 | 3,307,872 | 20,508,247 | ||||||||
State and local | 1,025,645 | 2,871,179 | (871,439) | ||||||||
Current income tax expense | 17,469,237 | 6,179,051 | 19,636,808 | ||||||||
Deferred Income Tax Expense (Benefit) [Abstract] | |||||||||||
U.S. Federal | 4,077,609 | (224,604) | (1,833,943) | ||||||||
State and local | 1,573,753 | 797,518 | (1,821,808) | ||||||||
Deferred income tax benefit | 5,651,362 | 572,914 | (3,655,751) | ||||||||
Income Tax Expense (Benefit) [Abstract] | |||||||||||
U.S. Federal | 20,521,201 | 3,083,268 | 18,674,304 | ||||||||
State and local | 2,599,398 | 3,668,697 | (2,693,247) | ||||||||
Income tax expenses (benefit) | $ 23,120,599 | $ 6,751,965 | $ 15,981,057 |
Income Taxes (Income Tax Reconc
Income Taxes (Income Tax Reconciliation) (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |||||||||
Mar. 31, 2021 | Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Sep. 30, 2019 | Jun. 30, 2019 | Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Income tax expense reconciliation to U.S. federal tax rate [Abstract] | |||||||||||
Expected income tax | $ 23,394,720 | $ 7,330,983 | $ 18,874,500 | ||||||||
Increase (reduction) in income taxes resulting from: | |||||||||||
State tax (excluding state tax credits), net of federal benefit | 2,053,524 | 3,398,271 | 1,576,915 | ||||||||
Federal tax credits (net) | 1,173,435 | 7,616,236 | 0 | ||||||||
State tax credits | 0 | (500,000) | (3,704,580) | ||||||||
Revalue deferred tax assets and liabilities | 0 | 0 | (852,523) | ||||||||
Uncertain tax positions | (2,107,263) | (167,455) | (183,929) | ||||||||
Nondeductible penalties | 8,274 | 4,562,830 | 2,210 | ||||||||
Executive compensation limitation under Section 162(m) | 1,203,203 | 1,305,975 | 37,457 | ||||||||
Excess tax benefits related to equity compensation | (996,769) | (612,987) | (287,703) | ||||||||
Prior year adjustments | (30,953) | (672,358) | 106,075 | ||||||||
Other, net | 769,298 | (277,058) | 412,635 | ||||||||
Foreign income adjustments | 0 | 0 | 626,583 | ||||||||
Income tax expenses (benefit) | $ 11,409,000 | $ 2,418,000 | $ 3,767,000 | $ 5,527,000 | $ 2,721,000 | $ 356,000 | $ 1,312,000 | $ 2,363,000 | 23,120,599 | 6,751,965 | 15,981,057 |
Discontinued Operations, Disposed of by Sale | |||||||||||
Income tax expense reconciliation to U.S. federal tax rate [Abstract] | |||||||||||
Expected income tax | 0 | 0 | 491,783 | ||||||||
Increase (reduction) in income taxes resulting from: | |||||||||||
Other, net | 0 | 0 | (53,174) | ||||||||
Foreign income adjustments | 0 | 0 | 187,974 | ||||||||
Income tax expenses (benefit) | $ 0 | $ 0 | $ 626,583 |
Income Taxes (Deferred Tax Asse
Income Taxes (Deferred Tax Assets and Liabilities) (Details) - USD ($) | Mar. 31, 2021 | Mar. 31, 2020 |
Deferred tax assets: | ||
Allowance for credit losses | $ 22,908,670 | $ 23,900,236 |
Unearned insurance commissions | 10,080,766 | 9,964,655 |
Accrued expenses primarily related to employee benefits | 13,676,701 | 12,730,245 |
Reserve for uncollectible interest | 645,113 | 1,205,082 |
Lease liability | 22,231,591 | 25,309,841 |
Foreign tax credit carryforward | 3,254,926 | 3,254,926 |
Capital loss carryforward | 7,928,184 | 7,784,059 |
State net operating loss carryforwards | 78,358 | 387,558 |
Gross deferred tax assets | 80,804,309 | 84,536,602 |
Less valuation allowance | (11,184,384) | (11,040,259) |
Net deferred tax assets | 69,619,925 | 73,496,343 |
Deferred tax liabilities: | ||
Fair value adjustment for loans receivable | (12,362,590) | (14,065,135) |
Property and equipment | (5,902,421) | (5,097,147) |
Intangible assets | (243,574) | (925,319) |
Deferred net loan origination costs | (1,268,653) | (1,664,486) |
Prepaid expenses | (1,412,337) | (1,185,759) |
Right-of-use asset | (21,826,178) | (25,045,690) |
Other | (1,611,430) | (2,254,822) |
Gross deferred tax liabilities | (44,627,183) | (50,238,358) |
Deferred income taxes, net | $ 24,992,742 | $ 23,257,985 |
Income Taxes (Unrecognized Tax
Income Taxes (Unrecognized Tax Benefits) (Details) - USD ($) | 12 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Reconciliation of the beginning and ending amount of unrecognized tax benefits [Roll Forward] | |||
Unrecognized tax benefit balance beginning of year | $ 4,351,811 | $ 4,043,623 | $ 6,946,229 |
Gross increases for tax positions of current year | 36,541 | 246,725 | 54,025 |
Gross increases (decreases) for tax positions of prior years | 0 | (786,674) | (138,405) |
Settlements with tax authorities | (1,968,702) | 0 | (1,356,714) |
Lapse of statute of limitations | (608,406) | (725,211) | (1,461,512) |
Unrecognized tax benefit balance end of year | $ 1,811,244 | $ 4,351,811 | $ 4,043,623 |
Earnings Per Share (Details)
Earnings Per Share (Details) - USD ($) | 12 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Income (Numerator) | |||
Income from continuing operations | $ 88,282,828 | $ 28,157,478 | $ 73,897,515 |
Shares (Denominator) | |||
Income available to common shareholders (in shares) | 6,493,898 | 7,688,242 | 8,994,036 |
Effect of dilutive securities options and restricted stock (in shares) | 178,212 | 264,658 | 210,341 |
Income available to common shareholders, diluted (in shares) | 6,672,110 | 7,952,900 | 9,204,377 |
Per Share Amount | |||
Income from continuing operations available to common shareholders, Basic (in dollar per share) | $ 13.59 | $ 3.66 | $ 8.22 |
Income from continuing operations available to common shareholders, dilutive (in dollar per share) | $ 13.23 | $ 3.54 | $ 8.03 |
Antdilutive securities (in shares) | 608,087 | 656,347 | 592,947 |
Benefit Plans (Details)
Benefit Plans (Details) | Oct. 15, 2018 | Mar. 31, 2021USD ($)quarterinstallmentshares | Mar. 31, 2021USD ($)quarterinstallment$ / sharesshares | Mar. 31, 2020USD ($)$ / sharesshares | Mar. 31, 2019USD ($)$ / sharesshares |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Maximum contribution from employer | 50.00% | ||||
Employer matching contribution, percent | 6.00% | ||||
Employer contribution, percent of match | 3.00% | ||||
Amount of cost recognized | $ 1,600,000 | $ 1,600,000 | $ 1,500,000 | ||
Annual salary increase used for estimating unfunded liability | 3.50% | ||||
Discount rate used for estimating unfunded liability | 6.00% | 6.00% | |||
Retirement age used for estimating unfunded liability | 65 | ||||
Stock Option Plans | |||||
Number of shares available for grant (in shares) | shares | 170,377 | 170,377 | |||
Percentage of shares subject to performance shares | 100.00% | ||||
Weighted-average fair value at the grant date | $ / shares | $ 58.48 | $ 57.69 | $ 53.50 | ||
Restricted Stock | |||||
Granted during the period (in dollars per share) | $ / shares | $ 101.61 | ||||
Schedule of vesting of restricted shares on basis of compounded annual EPS growth [Abstract] | |||||
Stock-based compensation | $ 19,281,278 | $ 28,952,161 | $ 17,635,309 | ||
Stock Options Plans | |||||
Stock Option Plans | |||||
Shares of authorized common stock reserved for issuance (in shares) | shares | 3,350,000 | 3,350,000 | |||
Compensation Cost Not yet Recognized | |||||
Total unrecognized stock-based compensation expense related to non-vested stock options | $ 8,400,000 | $ 8,400,000 | |||
Weighted average period for recognition | 3 years 8 months 12 days | ||||
Schedule of vesting of restricted shares on basis of compounded annual EPS growth [Abstract] | |||||
Weighted average period for recognition | 3 years 8 months 12 days | ||||
Stock-based compensation | $ 3,804,674 | $ 5,522,883 | $ 3,991,967 | ||
Restricted Stock | |||||
Stock Option Plans | |||||
Number of installments | installment | 6 | 6 | |||
Restricted Stock | |||||
Granted during the period (in shares) | shares | 52,735 | 11,223 | 760,420 | ||
Granted during the period (in dollars per share) | $ / shares | $ 106.28 | $ 90.23 | |||
Schedule of vesting of restricted shares on basis of compounded annual EPS growth [Abstract] | |||||
Stock-based compensation | $ 15,476,603 | $ 23,429,277 | $ 13,643,343 | ||
Unrecognized compensation cost related to unvested restricted stock | $ 27,200,000 | 27,200,000 | |||
Equity Classified Awards | |||||
Schedule of vesting of restricted shares on basis of compounded annual EPS growth [Abstract] | |||||
Stock-based compensation | $ 19,281,277 | 28,952,160 | 17,635,310 | ||
Performance Shares | |||||
Stock Option Plans | |||||
Vesting period | 10 years | ||||
Number of consecutive quarters | quarter | 4 | 4 | |||
Compensation Cost Not yet Recognized | |||||
Weighted average period for recognition | 2 years 6 months | ||||
Schedule of vesting of restricted shares on basis of compounded annual EPS growth [Abstract] | |||||
Weighted average period for recognition | 2 years 6 months | ||||
Service Options | |||||
Stock Option Plans | |||||
Vesting period | 10 years | ||||
Number of installments | installment | 6 | 6 | |||
Maximum | Stock Options Plans | |||||
Stock Option Plans | |||||
Expiration period | 10 years | ||||
Vesting period | 6 years | ||||
Supplemental Employee Retirement Plans, Defined Benefit | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Pension and other postretirement benefits cost (reversal of cost) | $ 550,000 | 580,000 | $ 650,000 | ||
Unfunded liability | $ 6,400,000 | $ 6,400,000 | $ 6,800,000 |
Benefit Plans (Stock Grant Fair
Benefit Plans (Stock Grant Fair Value Assumptions) (Details) - $ / shares | 12 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Dividend yield | 0.00% | 0.00% | 0.00% |
Expected volatility | 57.53% | 52.28% | 48.94% |
Average risk-free interest rate | 0.59% | 1.58% | 3.01% |
Expected life | 6 years 3 months 18 days | 6 years 3 months 18 days | 6 years 8 months 12 days |
Target 1 | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
EPS Targets (in dollars per share) | $ 16.35 | ||
Restricted Stock Eligible for Vesting (in hundredths) | 40.00% | ||
Target 2 | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
EPS Targets (in dollars per share) | $ 20.45 | ||
Restricted Stock Eligible for Vesting (in hundredths) | 60.00% | ||
Target 3 | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
EPS Targets (in dollars per share) | $ 25.30 | ||
Restricted Stock Eligible for Vesting (in hundredths) | 100.00% |
Benefit Plans (Option activity)
Benefit Plans (Option activity) (Details) - Stock Options Plans - USD ($) | 12 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Options Activity [Roll Forward] | |||
Options outstanding, beginning of year (in shares) | 646,728 | ||
Granted (in shares) | 38,473 | ||
Exercised (in shares) | (165,237) | ||
Forfeited (in shares) | (18,666) | ||
Expired (in shares) | (1,130) | ||
Options outstanding, end of period (in shares) | 500,168 | 646,728 | |
Options exercisable, end of period (in shares) | 213,095 | ||
Weighted Average Exercise Price [Roll Forward] | |||
Options outstanding, beginning of year (in dollars per share) | $ 88.30 | ||
Granted (in dollars per share) | 109.30 | ||
Exercised (in dollars per share) | 74.25 | ||
Forfeited (in dollars per share) | 105.14 | ||
Expired (in dollars per share) | 103.75 | ||
Options outstanding, end of period (in dollars per share) | 93.89 | $ 88.30 | |
Options exercisable, end of period (in dollars per share) | $ 81.47 | ||
Stock Option Activity Additional Disclosures | |||
Weighted-average remaining contractual term, Options outstanding, end of period | 6 years 3 months 14 days | ||
Weighted-average remaining contractual terms, Options exercisable, end of period | 4 years 1 month 9 days | ||
Aggregate intrinsic value, Options outstanding, end of period | $ 18,080,095 | ||
Aggregate intrinsic value, Options exercisable, end of period | 10,300,232 | ||
Intrinsic value of options exercised | $ 9,996,167 | $ 5,083,094 | $ 4,433,495 |
Benefit Plans (Restricted stock
Benefit Plans (Restricted stock) (Details) - $ / shares | 12 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] | |||
Granted during the period (in dollars per share) | $ 101.61 | ||
Restricted Stock | |||
Summary of the status and changes in restricted stock [Roll Forward] | |||
Outstanding at beginning of period (in shares) | 705,254 | ||
Granted during the period (in shares) | 52,735 | 11,223 | 760,420 |
Vested during the period (in shares) | 83,250 | ||
Forfeited during the period (in shares) | 60,000 | ||
Outstanding at end of period (in shares) | 614,739 | 705,254 | |
Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] | |||
Outstanding at beginning of period (in dollars per share) | $ 101.47 | ||
Granted during the period (in dollars per share) | 106.28 | $ 90.23 | |
Vested during the period (in dollars per share) | 101.17 | ||
Forfeited during the period (in dollars per share) | 100.79 | ||
Outstanding at end of period (in dollars per share) | $ 101.99 | $ 101.47 |
Benefit Plans (Stock-based comp
Benefit Plans (Stock-based compensation) (Details) - USD ($) | 12 Months Ended | ||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Stock-based compensation | $ 19,281,278 | $ 28,952,161 | $ 17,635,309 |
Stock Options Plans | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Stock-based compensation | 3,804,674 | 5,522,883 | 3,991,967 |
Restricted Stock | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Stock-based compensation | 15,476,603 | 23,429,277 | 13,643,343 |
Equity Classified Awards | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Stock-based compensation | $ 19,281,277 | $ 28,952,160 | $ 17,635,310 |
Acquisitions (Details)
Acquisitions (Details) | 12 Months Ended | ||
Mar. 31, 2021USD ($)acquisition | Mar. 31, 2020USD ($)acquisition | Mar. 31, 2019USD ($)acquisition | |
Business Acquisition [Line Items] | |||
Number of branches acquired through business combinations | acquisition | 0 | 38 | 17 |
Number of asset purchases | acquisition | 50 | 140 | 88 |
Total acquisitions | acquisition | 50 | 178 | 105 |
Loans receivable, net | $ 15,210,973 | $ 47,026,694 | $ 33,920,847 |
Property and equipment | 0 | 74,000 | 1,500 |
Tangible assets | 15,210,973 | 47,100,694 | 33,922,347 |
Excess of purchase prices over fair value of net tangible assets | 4,563,279 | 14,455,279 | 10,223,440 |
Customer lists | 4,365,779 | 13,228,951 | 9,688,440 |
Non-compete agreements | 197,500 | 890,000 | 535,000 |
Goodwill | $ 0 | 336,328 | 0 |
Average loan life | 8 months | ||
Series of Business Acquisitions | |||
Business Acquisition [Line Items] | |||
Purchase price | $ 19,774,252 | $ 61,555,973 | $ 44,145,787 |
Fair Value (Details)
Fair Value (Details) - USD ($) | 12 Months Ended | |
Mar. 31, 2021 | Mar. 31, 2020 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Average loan life | 8 months | |
Senior notes payable | $ 405,007,500 | $ 451,100,000 |
Impairment loss | 251,000 | |
Fair Value, Inputs, Level 1 | Book value | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 15,746,454 | 11,618,922 |
Fair Value, Inputs, Level 1 | Estimate of Fair Value Measurement | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | 15,746,454 | 11,618,922 |
Fair Value, Inputs, Level 3 | Book value | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans receivable, net | 733,659,389 | 804,402,786 |
Fair Value, Inputs, Level 3 | Book value | Senior notes payable | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Senior notes payable | 405,007,500 | 451,100,000 |
Fair Value, Inputs, Level 3 | Estimate of Fair Value Measurement | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans receivable, net | 733,659,389 | 804,402,786 |
Fair Value, Inputs, Level 3 | Estimate of Fair Value Measurement | Senior notes payable | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Senior notes payable | 405,007,500 | 451,100,000 |
Fair Value, Inputs, Level 2 | Book value | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets held for sale | 1,143,528 | 3,991,498 |
Fair Value, Inputs, Level 2 | Estimate of Fair Value Measurement | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets held for sale | $ 1,143,528 | $ 3,991,498 |
Quarterly Information (Unaudi_3
Quarterly Information (Unaudited) (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |||||||||
Mar. 31, 2021 | Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Sep. 30, 2019 | Jun. 30, 2019 | Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | |
Selected Quarterly Financial Information [Abstract] | |||||||||||
Total revenues | $ 146,280,000 | $ 130,946,000 | $ 124,441,000 | $ 123,867,000 | $ 163,018,000 | $ 146,996,000 | $ 141,573,000 | $ 138,441,000 | $ 525,533,267 | $ 590,029,015 | $ 544,542,925 |
Provision for credit losses | 5,636,000 | 28,857,000 | 26,090,000 | 25,661,000 | 32,252,000 | 55,219,000 | 52,968,000 | 41,291,000 | 86,244,714 | 181,730,182 | 148,426,578 |
General and administrative expenses | 77,411,000 | 77,875,000 | 75,293,000 | 71,608,000 | 96,707,000 | 90,558,000 | 78,452,000 | 81,776,000 | 302,186,290 | 347,493,260 | 288,303,715 |
Interest expense | 6,940,000 | 7,305,000 | 5,893,000 | 5,562,000 | 8,035,000 | 7,130,000 | 6,328,000 | 4,403,000 | 25,698,836 | 25,896,130 | 17,934,060 |
Income tax expense | 11,409,000 | 2,418,000 | 3,767,000 | 5,527,000 | 2,721,000 | 356,000 | 1,312,000 | 2,363,000 | 23,120,599 | 6,751,965 | 15,981,057 |
Income (loss) from discontinued operations | 0 | 0 | (36,662,381) | ||||||||
Net income | $ 44,884,000 | $ 14,491,000 | $ 13,398,000 | $ 15,509,000 | $ 23,303,000 | $ (6,267,000) | $ 2,513,000 | $ 8,608,000 | $ 88,282,828 | $ 28,157,478 | $ 37,235,134 |
Earnings per share: | |||||||||||
Basic (in dollars per share) | $ 7.25 | $ 2.32 | $ 2.01 | $ 2.26 | $ 3.23 | $ (0.87) | $ 0.32 | $ 1.01 | $ 13.59 | $ 3.66 | $ 4.14 |
Diluted (in dollars per share) | $ 6.96 | $ 2.25 | $ 1.96 | $ 2.24 | $ 3.18 | $ (0.87) | $ 0.31 | $ 0.97 | $ 13.23 | $ 3.54 | $ 4.05 |
Assets Held for Sale (Details)
Assets Held for Sale (Details) | 3 Months Ended | 12 Months Ended | |
Dec. 31, 2020USD ($)building | Mar. 31, 2020USD ($) | Mar. 31, 2021USD ($) | |
Property, Plant and Equipment [Abstract] | |||
Number of buildings sold | building | 2 | ||
Number of buildings | building | 3 | ||
Gain (Loss) on Sale of Properties | $ (37,579) | ||
Impairment loss | $ 251,000 | ||
Total assets held for sale | $ 3,991,498 | $ 1,143,528 |
Discontinued Operations (Detail
Discontinued Operations (Details) - USD ($) | 12 Months Ended | |||
Mar. 31, 2021 | Mar. 31, 2020 | Mar. 31, 2019 | Jul. 01, 2018 | |
Discontinued Operations and Disposal Groups [Abstract] | ||||
Consideration for disposal | $ 44,400,000 | |||
Revenues | $ 0 | $ 0 | $ 9,693,367 | |
Provision for loan losses | 0 | 0 | 1,809,059 | |
General and administrative expenses | 0 | 0 | 5,542,483 | |
Income from discontinued operations before disposal of discontinued operations and income taxes | 0 | 0 | 2,341,825 | |
Loss on disposal of discontinued operations | 0 | 0 | (38,377,623) | |
Income taxes (benefit) | 0 | 0 | 626,583 | |
Income (loss) from discontinued operations | 0 | 0 | (36,662,381) | |
Cash provided by operating activities: | 0 | 0 | 3,553,854 | |
Cash provided by (used in) investing activities: | 0 | 0 | 1,138,084 | |
Cash provided by (used in) financing activities: | $ 0 | $ 0 | $ (17,126,000) |